<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4531301</article-id><article-id pub-id-type="doi">10.3389/fimmu.2015.00406</article-id><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Hypothesis and Theory</subject></subj-group></subj-group></article-categories><title-group><article-title>A Hitchhiker&#x02019;s Guide to Myeloid Cell Subsets: Practical Implementation of a Novel Mononuclear Phagocyte Classification System</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Guilliams</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1">*</xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/152483"/></contrib><contrib contrib-type="author"><name><surname>van de Laar</surname><given-names>Lianne</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1">*</xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/256643"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Laboratory of Immunoregulation, VIB Inflammation Research Center, Ghent University</institution>, <addr-line>Ghent</addr-line>, <country>Belgium</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Respiratory Medicine, University Hospital Ghent</institution>, <addr-line>Ghent</addr-line>, <country>Belgium</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Ken J. Ishii, National Institute of Biomedical Innovation, Japan</p></fn><fn fn-type="edited-by"><p>Reviewed by: Richard A. Kroczek, Robert Koch-Institute, Germany; Kazuhiro Suzuki, Osaka University, Japan</p></fn><corresp content-type="corresp" id="cor1">*Correspondence: Martin Guilliams and Lianne van de Laar, Laboratory of Immunoregulation, VIB Inflammation Research Center, Ghent University, Technologiepark 927, Zwijnaarde, 9052 Ghent, Belgium, <email>martin.guilliams@irc.vib-ugent.be</email>; <email>lianne.vandelaar@irc.vib-ugent.be</email></corresp><fn fn-type="other" id="fn001"><p>Specialty section: This article was submitted to Antigen Presenting Cell Biology, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>11</day><month>8</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>6</volume><elocation-id>406</elocation-id><history><date date-type="received"><day>13</day><month>6</month><year>2015</year></date><date date-type="accepted"><day>24</day><month>7</month><year>2015</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2015 Guilliams and van de Laar.</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Guilliams and van de Laar</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>The classification of mononuclear phagocytes as either dendritic cells or macrophages has been mainly based on morphology, the expression of surface markers, and assumed functional specialization. We have recently proposed a novel classification system of mononuclear phagocytes based on their ontogeny. Here, we discuss the practical application of such a classification system through a number of prototypical examples we have encountered while hitchhiking from one subset to another, across species and between steady-state and inflammatory settings. Finally, we discuss the advantages and drawbacks of such a classification system and propose a number of improvements to move from theoretical concepts to concrete guidelines.</p></abstract><kwd-group><kwd>nomenclature</kwd><kwd>dendritic cells</kwd><kwd>macrophages</kwd><kwd>monocytes</kwd><kwd>classification</kwd></kwd-group><counts><fig-count count="7"/><table-count count="0"/><equation-count count="0"/><ref-count count="124"/><page-count count="12"/><word-count count="9338"/></counts></article-meta></front><body><sec sec-type="intro" id="S1"><title>Introduction</title><p>In the science fiction series created by Douglas Adams (<xref rid="B1" ref-type="bibr">1</xref>), the Hitchhiker&#x02019;s Guide to the Galaxy starts as follows: &#x0201c;<italic>Space is big. Really big. You just won&#x02019;t believe how vastly hugely mind-boggling big it is. You may think it&#x02019;s a long way down the road to the chemist&#x02019;s, but that&#x02019;s just peanuts to space</italic>.&#x0201d; Given the complexity of the mononuclear phagocyte (Star)system (MPS), one could easily give a similar warning to readers who are trying to make some sense of the huge number of hypothetically distinct dendritic cell (DC) and macrophage (M&#x003a6;) subsets. At the last International DC Symposium (DC2014, Tours&#x02009;&#x02013;&#x02009;France), we counted at least 28 different DC subsets that were described using various surface markers and nomenclature systems in distinct species. If one would add the different M&#x003a6; subsets and the Cytof technology allowing to measure the expression of more than 30 different surface markers per cell, one could with a bit of luck end up with &#x0201c;42&#x0201d; as answer to the ultimate myeloid question of how many mononuclear phagocyte subsets exist in life, the universe, and everything. Although this would be great for fans of Douglas Adams, without Babel Fish to help us make some sense of so many different subsets, this evolution will not be beneficial for communication among myeloid cell experts, let alone for the communication toward pharmaceutical companies, scientific editors, medical doctors, or graduate students. We will here try to simplify this apparent complexity through a number of practical examples and theoretical concepts. Having hitchhiked from M&#x003a6; to DC labs studying myeloid cells in various tissues and in distinct inflammatory conditions, we would, in accordance with the Hitchhiker&#x02019;s Guide to the Galaxy, advise the following: do not panic and bring your towel along.</p></sec><sec id="S2"><title>Members of the Mononuclear Phagocyte System</title><p>In the original MPS model proposed by Ralph van Furth, James Hirsch, and Zanvil Cohn, M&#x003a6;s were proposed to derive from circulating monocytes (<xref rid="B2" ref-type="bibr">2</xref>). A couple of years later, Ralph Steinman and Zanvil Cohn identified DCs, which were also included in the MPS (<xref rid="B3" ref-type="bibr">3</xref>). The fact that DCs could be derived from human and mouse monocytes in GM-CSF-driven <italic>in vitro</italic> cultures (<xref rid="B4" ref-type="bibr">4</xref>&#x02013;<xref rid="B8" ref-type="bibr">8</xref>) and <italic>in vivo</italic> upon inflammation or in barrier tissues (<xref rid="B9" ref-type="bibr">9</xref>&#x02013;<xref rid="B15" ref-type="bibr">15</xref>) supported this concept. For a historical overview of the MPS field, we redirect the readers to the review of Simon Yona and Siamon Gordon in this issue (<xref rid="B16" ref-type="bibr">16</xref>). The identification of mouse hematopoietic precursors committed to the DC lineage called the common DC progenitors (CDPs&#x02009;&#x02013;&#x02009;giving rise to pDCs and cDCs) and pre-cDCs (giving rise to cDCs) that are distinct from monocytes and can give rise to the so-called conventional DCs (cDCs) induced a first conceptual revolution in the field (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B17" ref-type="bibr">17</xref>&#x02013;<xref rid="B20" ref-type="bibr">20</xref>). Moreover, Flt3-L, and not GM-CSF, was shown to be critically involved in the development of cDCs <italic>in vitro</italic> (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B21" ref-type="bibr">21</xref>&#x02013;<xref rid="B23" ref-type="bibr">23</xref>) and <italic>in vivo</italic> (<xref rid="B24" ref-type="bibr">24</xref>&#x02013;<xref rid="B28" ref-type="bibr">28</xref>). Recently, two additional committed precursors were identified in mice: the pre-pDC precursor that preferentially differentiates into pDCs (<xref rid="B29" ref-type="bibr">29</xref>), and the monocyte-committed common monocyte progenitor (cMop) (<xref rid="B30" ref-type="bibr">30</xref>). Importantly, the human equivalent of the pre-cDC, CDP, and cMop was recently identified (<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B32" ref-type="bibr">32</xref>). A second conceptual revolution in the field was driven by the finding that most tissue-resident M&#x003a6;s do not derive from circulating HSC-derived monocytes but develop from embryonic precursors, i.e., the yolk-sac M&#x003a6;s (YS M&#x003a6;s) or fetal liver (FL) monocytes (<xref rid="B33" ref-type="bibr">33</xref>&#x02013;<xref rid="B39" ref-type="bibr">39</xref>). The relative contribution of YS M&#x003a6;-derived and FL monocyte-derived M&#x003a6;s seems to vary from one organ to another (<xref rid="B40" ref-type="bibr">40</xref>&#x02013;<xref rid="B42" ref-type="bibr">42</xref>). It was recently demonstrated that almost all M&#x003a6;s have a YS origin [either directly from YS M&#x003a6;s or through YS-derived EMPs (<xref rid="B39" ref-type="bibr">39</xref>)]. This may seem in contradiction with the proposed partial origin from FL monocytes (<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B43" ref-type="bibr">43</xref>). However, it is now clear that YS-derived EMPs seed the FL and go through a FL monocyte intermediate before differentiating into most tissue-resident M&#x003a6;s (<xref rid="B44" ref-type="bibr">44</xref>), reconciling most of the apparent discrepancies in the field. Together, these findings have challenged the MPS dogma and revealed that most DCs and M&#x003a6;s derive from distinct committed precursors rather than from circulating HSC-derived monocytes (Figure <xref ref-type="fig" rid="F1">1</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Mononuclear phagocytes and their precursors</bold>. Note that this is work in progress and technical advances such as single-cell RNASeq and barcoding will in the near future prove or disprove many aspect of this theoretical scheme.</p></caption><graphic xlink:href="fimmu-06-00406-g001"/></fig></sec><sec id="S3"><title>Revisiting the Classification of Mononuclear Phagocytes</title><p>Historically, mononuclear phagocytes were classified as DCs or M&#x003a6;s based on a restricted set of surface markers (CD11c and MHCII for DCs versus F4/80 for M&#x003a6;s), proposed functional specialization (antigen-presentation and migration to lymph nodes for DCs versus phagocytosis for M&#x003a6;s) and/or morphological features (dendritic-shaped cells for DCs versus large vacuolar cells for M&#x003a6;s). However, these features are often not mutually exclusive. For example, although CD11c and MHCII are typically associated with DCs, alveolar M&#x003a6; are CD11c<sup>hi</sup> and MHCII is expressed by intestinal M&#x003a6;s (<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B45" ref-type="bibr">45</xref>). Ideal surface markers allowing identification of the distinct myeloid cell subsets across tissues and species are still incomplete. Markers typically associated with some myeloid cell subsets can be lost or acquired by other subsets. The monocyte-associated marker Ly-6C is rapidly down-regulated on many monocyte-derived cells (MCs) upon entrance in the tissues (<xref rid="B45" ref-type="bibr">45</xref>&#x02013;<xref rid="B48" ref-type="bibr">48</xref>) and is expressed on pDCs (and lowly expressed on some cDCs). The pDC-associated marker mPDCA1 (stained with 120G8) can be acquired by MCs during inflammation (<xref rid="B49" ref-type="bibr">49</xref>). Alveolar M&#x003a6;s (<xref rid="B50" ref-type="bibr">50</xref>) and Kupffer Cells (unpublished data) can upregulate CD11b during inflammation. Finally, BDCA3 is expressed on both human cDC1s and MCs (<xref rid="B51" ref-type="bibr">51</xref>). Thus, the inability to consistently identify myeloid cell subsets irrespective of tissue, species, or inflammatory state makes surface markers unattractive as basis for classification.</p><p>We would also propose to avoid a classification based primarily on functional specialization. First, each myeloid cell subset can perform more than one prototypical function. M&#x003a6;s are often linked to phagocytosis of dead cells and pathogens but also have important immunomodulatory and metabolic functions. Second, subsets can acquire or lose functional capacities during inflammation as recently demonstrated for cDC2s that acquire cross-presentation capacities upon TLR stimulation (<xref rid="B52" ref-type="bibr">52</xref>). Therefore, we propose to disregard function as a basis for classifying cells.</p><p>Instead of surface markers, functional specialization, or morphology, we have recently suggested to classify cells based on their cellular origin, which could allow a more robust classification system (<xref rid="B53" ref-type="bibr">53</xref>). This would yield three big groups of cells (Figure <xref ref-type="fig" rid="F1">1</xref>): (i) embryonic progenitor-derived M&#x003a6;s, (ii) CDP-derived DCs (that would be subdivided into cDC1s, cDC2s, and pDCs), and (iii) MCs. As these precursors have now been identified in both the mouse and the human, this allows one classification system across tissues and species.</p><p>Although precursor-based classification would provide a robust and species-conserved system, at the end of the day the function of the cells is what really matters for converting our knowledge into therapeutic advances for patients. Regrouping all the DCs into three big subsets of cDC1s, cDC2s, and pDCs will thus have the disadvantage of lumping together cells that may be in very different functional activation states. Similarly, MCs have been shown to be particularly plastic cells (<xref rid="B54" ref-type="bibr">54</xref>). Therefore, we propose to add a second classification level to the fixed ontogeny-based Level1 (Figure <xref ref-type="fig" rid="F2">2</xref>). Addition of a Level2 allows specification of the cellular activation state, the micro-anatomical localization or simply the surface markers utilized to identify the cells in a particular study. Of note, when defining the Level2 it will be important to avoid generalizations as a given function is often performed by only a fraction of the cells studied. We would thus propose to restrict the Level2 to objective criteria that can be measured at the single-cell level.</p><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>A nomenclature system in two levels would have the advantage that cells can be first classified based on a restricted set of names (in this proposition according to their cellular origin: M&#x003a6;, MC, cDC1, cDC2, pDC) that would be applicable across species and across tissues, but the second level would still allow some flexibility to denote a distinct activation state or localization</bold>.</p></caption><graphic xlink:href="fimmu-06-00406-g002"/></fig></sec><sec id="S4"><title>Practical Implementation for DCs</title><p>Historically, DCs were divided into subsets based on surface markers that differed between tissues and species, such as CD207 (Langerin) in the skin, CD103 (Integrin&#x003b1;E) in the intestine, CD11b (Integrin&#x003b1;M) in the lungs, CD4/CD8&#x003b1; in the spleen, and CD24/CD172&#x003b1; for <italic>in vitro</italic> differentiated DCs (Figure <xref ref-type="fig" rid="F3">3</xref>). Human DCs, on the other hand, have been divided into CD141<sup>+</sup> (BDCA3) and CD1c<sup>+</sup> (BDCA1) DCs. pDCs are identified by the expression of BDCA4 and BDCA2 in human, but by B220, mPDCA1 (BST2, recognized by 120G8), or Siglec-H in mice (<xref rid="B53" ref-type="bibr">53</xref>). Technical advances in multi-color flow cytometry have made matters worse with evermore &#x0201c;novel DC subsets&#x0201d; based on the expression of additional surface markers. By comparing the gene-expression profile of DCs isolated from various tissues and species, one can appreciate three big clusters of DCs (<xref rid="B55" ref-type="bibr">55</xref>&#x02013;<xref rid="B61" ref-type="bibr">61</xref>). The pDC cluster includes mouse PDCA1<sup>+</sup> pDCs and human BDCA2<sup>+</sup>BDCA4<sup>+</sup> pDCs. The cDC1 cluster comprises dermal CD207<sup>+</sup>CD103<sup>+</sup> cDC1s, lung CD103<sup>+</sup>CD11b<sup>&#x02212;</sup>cDC1s, splenic CD8a<sup>+</sup>CD4<sup>&#x02212;</sup> cDC1s, intestinal CD103<sup>+</sup>CD11b<sup>&#x02212;</sup> cDC1s and human blood BDCA3<sup>+</sup> cDC1s. Dermal CD207<sup>&#x02212;</sup>CD11b<sup>+</sup> cDC2s, lung CD103<sup>&#x02212;</sup>CD11b<sup>+</sup> cDC2s, splenic CD8a<sup>&#x02212;</sup>CD4<sup>+</sup> cDC2s, intestinal CD103<sup>+</sup>CD11b<sup>+</sup> cDC2s and human blood BDCA1<sup>+</sup> cDC2s form the cDC2 cluster (<xref rid="B62" ref-type="bibr">62</xref>, <xref rid="B63" ref-type="bibr">63</xref>). This bio-IT-driven analysis also revealed that within the cDC population, XCR1 and Sirp&#x003b1; are, respectively, expressed by all cDC1s and cDC2s across tissues, allowing an improved identification of these cells (<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B64" ref-type="bibr">64</xref>&#x02013;<xref rid="B70" ref-type="bibr">70</xref>). Note, however, that Sirp&#x003b1; is also expressed by other myeloid cells than cDC2s, showing the need for correct cDC identification prior to using this marker to distinguish cDC2s from cDC1s. Strikingly, this gene-expression-based division is supported by the existence of distinct pre-committed precursors (<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B71" ref-type="bibr">71</xref>, <xref rid="B72" ref-type="bibr">72</xref>) and by differential developmental transcription factor requirement of cDC1s, cDC2s, and pDCs in the mouse. cDC1s, but not cDC2s, require BATF3 (<xref rid="B71" ref-type="bibr">71</xref>, <xref rid="B73" ref-type="bibr">73</xref>, <xref rid="B74" ref-type="bibr">74</xref>), ID2 (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B75" ref-type="bibr">75</xref>, <xref rid="B76" ref-type="bibr">76</xref>), NFIL3 (<xref rid="B77" ref-type="bibr">77</xref>), and IRF8 (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B71" ref-type="bibr">71</xref>, <xref rid="B78" ref-type="bibr">78</xref>&#x02013;<xref rid="B80" ref-type="bibr">80</xref>) for their development, while cDC2s, but not cDC1s, are dependent on RELB (<xref rid="B81" ref-type="bibr">81</xref>), RBPJ (<xref rid="B82" ref-type="bibr">82</xref>), and IRF4 (<xref rid="B79" ref-type="bibr">79</xref>, <xref rid="B83" ref-type="bibr">83</xref>&#x02013;<xref rid="B85" ref-type="bibr">85</xref>). pDC development has been shown to be driven by E2-2 (<xref rid="B86" ref-type="bibr">86</xref>, <xref rid="B87" ref-type="bibr">87</xref>).</p><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>Murine DCs have been subdivided into many different subsets based on distinct surface markers in the spleen, the skin, the intestine, and the lung</bold>.</p></caption><graphic xlink:href="fimmu-06-00406-g003"/></fig><p>The subdivision of DCs in three distinct Level1 groups is thus supported by their gene-expression profiles, cellular origin, and transcription factor requirement. However, these cells can acquire a distinct functional activation state from one tissue to another and in distinct inflammatory settings, underlining the need for a Level2 system. This can be illustrated by the capacity of intestinal cDCs to produce retinoic acid and promote the generation of induced regulatory T cells (iT<sub>REGs</sub>) (<xref rid="B88" ref-type="bibr">88</xref>&#x02013;<xref rid="B91" ref-type="bibr">91</xref>). Identification of DCs with superior iT<sub>REG</sub> inducing ability is clinically relevant as the prevalence of food allergies, celiac disease and inflammatory bowel diseases is currently rising throughout the western world. Originally, it was described that CD103<sup>+</sup> but not CD103<sup>&#x02212;</sup> intestinal DCs excel in iT<sub>REG</sub> generation in a retinoic acid-dependent manner (<xref rid="B89" ref-type="bibr">89</xref>, <xref rid="B90" ref-type="bibr">90</xref>). It is now clear that CD103<sup>+</sup> intestinal DCs comprise two ontogenically distinct subsets, CD103<sup>+</sup>CD11b<sup>&#x02212;</sup> cDC1s and CD103<sup>+</sup>CD11b<sup>+</sup> cDC2s (<xref rid="B74" ref-type="bibr">74</xref>). Interestingly, rather than being associated with either of the two subsets, about half of the intestinal CD103<sup>+</sup>CD11b<sup>&#x02212;</sup> cDC1s were shown to possess the capacity to produce retinoic acid, while only one-third of the cDC2s do (<xref rid="B91" ref-type="bibr">91</xref>). Moreover, on a per cell basis retinoic acid producing CD103<sup>+</sup> cDC1s were the best at inducing iT<sub>REGs</sub> (Figure <xref ref-type="fig" rid="F4">4</xref>). These data reveal that CD103<sup>+</sup> cDC1s, although broadly considered as a homogeneous subset, consist of 50% cells that are very efficient at inducing iT<sub>REGs</sub> and 50% cells that are not. Interestingly, dermal cDC2s have higher retinoic acid-dependent iT<sub>REG</sub> induction activity than dermal cDC1s (<xref rid="B91" ref-type="bibr">91</xref>). We hypothesize that this functional heterogeneity may be explained by the existence of distinct micro-environments within organs, inducing diverse functional modules on DCs. The finding that important functional modules can be acquired by only a fraction of cDC1s and/or cDC2s, which can moreover differ from one organ to another, illustrates the need for a Level2 nomenclature for DCs.</p><fig id="F4" position="float"><label>Figure 4</label><caption><p><bold>Existence of subpopulations with distinct retinoic acid-producing capacities within both cDC1s and cDC2s in the mesenteric lymph nodes of mice</bold>. The capacity to produce retinoic acid was measured by the Aldefluor kit (<xref rid="B91" ref-type="bibr">91</xref>). DCs were sorted, loaded with the ovalbumin-peptide, and co-cultured <italic>in vitro</italic> with na&#x000ef;ve OTII cells to measure the induction of Foxp3 on these cells.</p></caption><graphic xlink:href="fimmu-06-00406-g004"/></fig><p>Another example of functional heterogeneity within DCs concerns the cDC2s. Splenic cDC2s contain a subpopulation that expresses CD4 and is specifically localized in the bridging channels (<xref rid="B92" ref-type="bibr">92</xref>). This localization has been shown to be EBI2-driven and essential to drive antibody production by B cells. The development of these CD4<sup>+</sup> cDC2s is Notch2 dependent. Note also that Notch2 deficiency is associated with defects in T<sub>H</sub>17 induction (<xref rid="B93" ref-type="bibr">93</xref>, <xref rid="B94" ref-type="bibr">94</xref>). In addition, it was found that KLF4 controls the development of a subpopulation of CD24<sup>lo</sup>CD11b<sup>lo</sup>Sirp&#x003b1;<sup>hi</sup> cDC2s in the dermis (<xref rid="B95" ref-type="bibr">95</xref>). Importantly, loss of KLF4 was associated with loss of T<sub>H</sub>2 induction. Thus, although cDC2s have been proposed to excel at both the induction of T<sub>H</sub>2 (<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B96" ref-type="bibr">96</xref>) and T<sub>H</sub>17 responses (<xref rid="B84" ref-type="bibr">84</xref>, <xref rid="B85" ref-type="bibr">85</xref>, <xref rid="B93" ref-type="bibr">93</xref>), it may well be that these functional modules are in fact expressed by subpopulations of cDC2s (controlled by KLF4 and Notch2, respectively). In conclusion, although the current knowledge of early DC development in the bone-marrow seems to support only three big groups of DCs (cDC1s, cDC2s, and pDCs), it appears that a second layer of tissue-specific signals imprint operative gene modules on a fraction of DCs. Depending on their micro-localization, subpopulations of cDC1s, cDC2s, or pDCs will acquire distinct functional properties, requiring a flexible Level2 to classify and describe functionally distinct subpopulations.</p><p>A final example of a need for a Level2 classification involves inflammation-induced changes of surface marker expression. When mice are infected with the influenza virus, there is a transient change in the CD103 versus CD11b expression profile of lung cDCs, yielding four instead of two lung DC subsets (Figure <xref ref-type="fig" rid="F5">5</xref>). If one considers these as four distinct DC subsets, one could conclude that influenza infection disrupts hematopoiesis in the bone-marrow, as has been shown for Toxoplasma infection (<xref rid="B97" ref-type="bibr">97</xref>). Alternatively, these novel CD103/CD11b expression patterns may represent distinct local activation states of cDC1s or cDC2s. We have studied the cellular origin of the &#x0201c;novel&#x0201d; DC subsets arising during influenza infection (Neyt et al., manuscript in preparation). Our preliminary data suggest that CD103<sup>+</sup>CD11b<sup>+</sup> cells are cDC2s that acquire CD103 expression during inflammation rather than a completely new subset. In conclusion, although we cannot rule out the existence of additional DC subsets that specifically develop during inflammation, when in doubt we propose to first evaluate whether cells with a novel surface receptor expression profile represent a different activation state of cDC1s or cDC2s before assuming the existence of a novel cDC3.</p><fig id="F5" position="float"><label>Figure 5</label><caption><p><bold>Inflammation can induce the appearance of &#x0201c;novel&#x0201d; DC subsets</bold>. CD103 and CD11b expression on cDCs from uninfected or influenza-infected lungs are shown. The appearance of CD103<sup>+</sup>CD11b<sup>+</sup> DCs and CD103<sup>&#x02212;</sup>CD11b<sup>&#x02212;</sup> DCs is transient as schematically represented.</p></caption><graphic xlink:href="fimmu-06-00406-g005"/></fig></sec><sec id="S5"><title>Practical Implementation for Embryonic Macrophages</title><p>In our classification system based on ontogeny all mononuclear phagocytes of embryonic origin are grouped together under a single Level1 as &#x0201c;macrophages&#x0201d; (Figure <xref ref-type="fig" rid="F1">1</xref>). This includes liver-resident Kupffer cells, brain-resident microglial cells, lung-resident alveolar M&#x003a6;s but also epidermis-resident Langerhans cells. In effect, this would thus classify Langerhans cells as M&#x003a6;s and not as DCs, based on the fact that these cells derive from embryonic precursors that seed the epidermis around birth and then self-maintain throughout life (<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B98" ref-type="bibr">98</xref>). We propose to keep the historical names for M&#x003a6;s with undisputed identities. Mouse Kupffer cells, for example, do not require a different nomenclature since these cells have a well-defined cellular origin [embryonic (<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>)], localization (i.e., the liver sinusoids), and gene-expression profile (<xref rid="B99" ref-type="bibr">99</xref>, <xref rid="B100" ref-type="bibr">100</xref>). However, we would like to emphasize that not any F4/80<sup>+</sup> cell in the liver should be categorized as Kupffer cell. MCs infiltrating the liver during acetaminophen-induced injury also express F4/80 but are short-lived and acquire a gene-expression profile that is strikingly different from resident Kupffer cells (<xref rid="B100" ref-type="bibr">100</xref>). Similarly, MCs infiltrating the central nervous system during inflammation are short-lived and do not acquire the specific gene-expression profile of embryonic microglia (<xref rid="B101" ref-type="bibr">101</xref>&#x02013;<xref rid="B103" ref-type="bibr">103</xref>). As such, any M&#x003a6;-like cell in the liver or the brain should not be classified as Kupffer cell or microglia, respectively, as is often the case. Unfortunately, tools to correctly distinguish MCs from resident M&#x003a6;s have long been lacking. In a way, this is surprising given the huge difference in gene-expression profile between resident embryonic M&#x003a6;s and recruited MCs in these disease models. We have now identified several surface markers that are expressed by Kupffer cells but not MCs recruited during liver injury (Scott et al. manuscript in preparation) and we expect that given the striking heterogeneity of tissue-resident M&#x003a6;s (<xref rid="B104" ref-type="bibr">104</xref>, <xref rid="B105" ref-type="bibr">105</xref>) many of these M&#x003a6;-specific markers will be found. This will facilitate the correct classification of these cells and pave the way toward unraveling the functional differences between recruited MCs and tissue-resident embryonic M&#x003a6;s during inflammation.</p></sec><sec id="S6"><title>Practical Implementation for Monocyte-Derived Cells</title><p>Monocytes are particularly plastic cells. This can be appreciated using <italic>in vitro</italic> culture systems. Monocytes cultured with GM-CSF express some DC-like characteristics and have therefore long been referred to as moDCs. By contrast, culturing monocytes with M-CSF induces their differentiation into M&#x003a6;-like cells (moM&#x003a6;s). Adding IL-4 or IFN-&#x003b3; to M-CSF cultures further polarizes MCs into the so-called &#x0201c;classically activated M&#x003a6;s/M1s&#x0201d; or &#x0201c;alternatively activated M&#x003a6;s/M2s&#x0201d; (<xref rid="B106" ref-type="bibr">106</xref>), with strikingly different gene-expression profiles and metabolic modules (<xref rid="B107" ref-type="bibr">107</xref>). In a nomenclature system based on ontogeny, moDCs, M1s, or M2s are however first classified as MCs (Level1). In theory, this does not prevent further Level2 classification as &#x0201c;dendritic MCs,&#x0201d; &#x0201c;classically activated MCs,&#x0201d; or &#x0201c;alternatively activated MCs.&#x0201d; However, we feel this polarized classification implies functional characteristics that are often not assessed experimentally. For example, MCs classified as M1s are typically associated with pathogen killing, M2s with wound healing, and moDCs with antigen-presentation (Figure <xref ref-type="fig" rid="F6">6</xref>). However, the identification of &#x0201c;dendritic MCs/moDCs,&#x0201d; &#x0201c;classically activated MCs/M1s,&#x0201d; or &#x0201c;alternatively activated MCs/M2s&#x0201d; <italic>in vivo</italic> turned out to be very challenging. In fact, profiling of MCs isolated from various inflamed tissues or <italic>in vitro</italic> culture systems reveals that monocytes can acquire a much broader transcriptional repertoire than suggested by the three-way M1/M2/moDC model. In recent efforts to further characterize the heterogeneity of MC activation states, Schultze and colleagues compared the gene-expression profile of MCs stimulated with a vast array of cytokines and TLR ligands. Instead of yielding a polarized model, the unbiased bio-informatics-driven clustering approach revealed a spectrum model (<xref rid="B54" ref-type="bibr">54</xref>). In our view, this spectrum model can be taken one step further and include the &#x0201c;dendritic MCs/moDCs&#x0201d; derived from GM-CSF-induced bone-marrow cultures as yet another extreme of the continuum of cellular faiths that can be acquired by monocytes. Rather than unique end points, bacterial killing, wound-healing, and antigen-presentation represent three of many functional modules that can be acquired by MCs in a spectrum model that can be graphically represented by a continuous circle (Figure <xref ref-type="fig" rid="F6">6</xref>).</p><fig id="F6" position="float"><label>Figure 6</label><caption><p><bold>A modular spectrum model for monocyte-derived cells</bold>. Replacement of the polarized three-way M1/M2/moDC model by a spectrum model in which bacterial killing, wound-healing, and antigen-presentation represent only three of many functional modules that can be acquired by MCs.</p></caption><graphic xlink:href="fimmu-06-00406-g006"/></fig><p>One important consequence of the herein-described classification would be the regrouping of moDCs and moM&#x003a6;s under a single MC Level1. We feel this will represent an improvement for the field due to the lack of clear, mutually exclusive features that can be used to objectively separate moDCs from moM&#x003a6;s (<xref rid="B53" ref-type="bibr">53</xref>). This problem can be illustrated by the MCs present within inflamed mesenteric lymph nodes during an experimental model for colitis (<xref rid="B45" ref-type="bibr">45</xref>). In this study, we called these cells moM&#x003a6;s because they were CD64<sup>hi</sup>F4/80<sup>hi</sup> and excelled at phagocytosis (Figure <xref ref-type="fig" rid="F7">7</xref>). However, we could perfectly, like the Powrie group (<xref rid="B108" ref-type="bibr">108</xref>), have classified these cells as moDCs based on their CD11c<sup>hi</sup>MHCII<sup>hi</sup> profile, their localization within the T cell zone, their antigen-presentation capacity, or their dendritic morphology (Figure <xref ref-type="fig" rid="F7">7</xref>). By classifying these cells as CD64<sup>hi</sup>F4/80<sup>hi</sup> and/or CD11c<sup>hi</sup>MHCII<sup>hi</sup> MCs, they are recognized as one lineage, which will promote understanding and simplify communication between different research groups without preventing the study of DC-like or M&#x003a6;-like properties of specific MCs.</p><fig id="F7" position="float"><label>Figure 7</label><caption><p><bold>Microscopic characterization of MCs isolated from inflamed mesenteric lymph nodes in an experimental model for colitis</bold>. CD11c<sup>hi</sup>MHCII<sup>hi</sup>CD64<sup>hi</sup>F4/80<sup>hi</sup> cells were sorted and cultured <italic>in vitro</italic> to evaluate their morphology and capacity to phagocytose latex beads (<xref rid="B45" ref-type="bibr">45</xref>).</p></caption><graphic xlink:href="fimmu-06-00406-g007"/></fig><p>Finally, we do not expect MCs to be homogeneous in inflamed tissues. We and others found iNOS, the enzyme that is used by M&#x003a6;s to produce NO and that is classically associated with an M1 activation state, to be typically expressed by only 10% of MCs (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B109" ref-type="bibr">109</xref>). Since NO is bactericidal, suppressive for T cells, and can induce serious tissue damage, it makes perfect sense to study the factors that induce the expression of iNOS on a fraction of MCs. But by classifying these cells as &#x0201c;iNOS<sup>+</sup> MCs&#x0201d; instead of &#x0201c;M1 macrophages&#x0201d; or &#x0201c;TIP-DCs&#x0201d; one avoids to associate functions that have not been proven for these cells such as the antigen-presentation activity typically expected from DCs [in fact mice lacking monocytes showed identical T cell priming suggesting that TIP-DCs are not essential for this function (<xref rid="B11" ref-type="bibr">11</xref>)].</p></sec><sec id="S7"><title>The Tough Cases Part I: moDCs as Fourth DC Subset?</title><p>MCs fitting the complete list of characteristics attributed to moDC, including migratory and antigen-presentation capacities comparable to cDCs, are not easily identified <italic>in vivo</italic>. We have described migratory MCs upon house-dust mite (HDM) exposure in the lungs (<xref rid="B47" ref-type="bibr">47</xref>), but their migration is much less efficient as compared to cDCs and required very high (and non-physiological) doses of HDM. In fact, we found that the majority of HDM-induced pulmonary MCs are not migratory cells but instead play an important role in the secretion of inflammatory chemokines that orchestrate the local immune responses. Similarly, a low-grade migration of CCR2<sup>+</sup>CD64<sup>int</sup> MCs was described upon DSS inflammation in the skin but this was minor as compared to cDC migration (<xref rid="B48" ref-type="bibr">48</xref>). Moreover, compared to cDCs these dermal CCR2<sup>+</sup>CD64<sup>int</sup> MCs displayed a rather modest antigen&#x02013;antigen presentation capacity.</p><p>The most convincing pieces of evidence for cDC-like features of MCs come from <italic>in vitro</italic> culture systems. Bone-marrow cells cultured with GM-CSF yield cells with excellent antigen-presentation capacity that acquire CCR7, the chemokine receptor controlling migration of cDCs from tissues to lymph nodes, upon TLR stimulation and can migrate to the lymph nodes upon <italic>in vivo</italic> transfer (<xref rid="B110" ref-type="bibr">110</xref>, <xref rid="B111" ref-type="bibr">111</xref>). This culture system has been used in many labs and is globally accepted to yield a homogeneous population of moDCs. This concept was first challenged by a study using single-cell transcriptomics (<xref rid="B112" ref-type="bibr">112</xref>). Among LPS-stimulated GM-CSF-induced bone-marrow-derived moDCs, the majority of cells were found to show high expression of inflammatory genes such as TNF, IL1, and CXCL10, while a smaller subset had much lower expression of these genes but displayed a signature reminiscent of &#x0201c;mature DCs,&#x0201d; including high expression of CCR7 (<xref rid="B113" ref-type="bibr">113</xref>, <xref rid="B114" ref-type="bibr">114</xref>). This was originally interpreted as functional heterogeneity among moDCs. However, in what we consider a landmark paper, Reis e Sousa and colleagues now demonstrate that this minor &#x0201c;mature&#x0201d; population in fact represents cDC2s that contaminate these cultures. These cDC2s displayed lower production of inflammatory cytokines but much better CCR7-ligand-induced migration and antigen-presentation as compared to GM-CSF-induced MCs (<xref rid="B115" ref-type="bibr">115</xref>, <xref rid="B116" ref-type="bibr">116</xref>). This implies that many of the DC-like features of GM-CSF-induced moDCs should in fact not be attributed to MCs, but to a minor contaminating cDC2 population. All in all, both <italic>in vitro</italic> and <italic>in vivo</italic> data thus point toward a lower migration and antigen-presentation capacity of MCs as compared to cDCs, but conversely a higher production of inflammatory cytokines and chemokines. We therefore propose that in an inflamed organ the core business of cDCs will be migration to the draining lymph nodes and activation of na&#x000ef;ve T cells, whereas MCs will primarily orchestrate local inflammatory responses. Note that this has important consequences for DC-based vaccination strategies as this may explain why MC-based vaccines have only yielded modest clinical responses (<xref rid="B117" ref-type="bibr">117</xref>). The recent advances in cDC culture systems and the proper identification of committed circulating DC-precursors (<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B118" ref-type="bibr">118</xref>) may therefore pave the way toward more efficient cDC-based vaccination strategies.</p></sec><sec id="S8"><title>The Tough Cases Part II: Steady-State MCs Versus Embryonic Macrophages</title><p>Most M&#x003a6;-like cells present in steady-state tissues are of embryonic origin (<xref rid="B33" ref-type="bibr">33</xref>&#x02013;<xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B44" ref-type="bibr">44</xref>). However, puzzling exceptions have been reported. Although embryonic M&#x003a6;s colonize the intestine and the heart before birth, these cells are thereafter progressively replaced by MCs. Importantly, these cells are relatively short-lived and continuous monocyte-recruitment is required to maintain the MC pool in these tissues (<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B119" ref-type="bibr">119</xref>&#x02013;<xref rid="B121" ref-type="bibr">121</xref>). Similarly, monocytes are continuously recruited to the steady-state dermis (<xref rid="B48" ref-type="bibr">48</xref>). Therefore, while in some steady-state tissues, including the lung and the spleen, monocytes have been proposed to remain in an undifferentiated state (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B122" ref-type="bibr">122</xref>); in others, including the intestine, the skin, and the heart, they acquire a M&#x003a6;-like phenotype. The classification of MCs that differentiate in these steady-state organs and that replace the embryonic M&#x003a6;s is difficult. They do not fit the profile of the MCs that are recruited to inflamed tissues, including pulmonary infection (<xref rid="B36" ref-type="bibr">36</xref>), auto-immune brain inflammation (<xref rid="B101" ref-type="bibr">101</xref>, <xref rid="B102" ref-type="bibr">102</xref>), and acute liver injury (<xref rid="B100" ref-type="bibr">100</xref>), since in these inflammatory settings MCs do not replace the embryonic M&#x003a6;s and display a very different gene-expression profile. Future research will be required to compare the functional properties and gene-expression profile of the embryonic M&#x003a6;s present in the intestine, the skin, and the heart to the ones from the MCs that replace them with time. It will be interesting to compare the influence of tissue-imprinting to the intrinsic differences associated with their distinct cellular origin. Embryonic M&#x003a6;s were recently compared to their bone-marrow-derived counterparts that replace them after irradiation-induced depletion. It was found that both cells share between 50 and 90% of the tissue-specific epigenetic landscape (<xref rid="B105" ref-type="bibr">105</xref>). This emphasizes the importance of tissue-imprinting, but at the same time implies that between 10 and 50% of the epigenetic landscape could be governed by the cellular origin of the cells. Future research will be required to assess the functional relevance of these findings. In the meantime, the classification of M&#x003a6;-like MCs in steady-state tissues remains difficult.</p></sec><sec id="S9"><title>The Way Forward</title><p>The Level1 that forms the scaffold of the herein proposed classification system is in part based on elegant murine fate-mapping systems developed to study the cellular origin of M&#x003a6;s (<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B44" ref-type="bibr">44</xref>) and DCs [(<xref rid="B123" ref-type="bibr">123</xref>) and (<xref rid="B124" ref-type="bibr">124</xref>) in this issue]. Although the recent identification of committed DC-precursors distinct from monocytes in humans suggests that many of the principles identified in mice apply to the human immune system, this remains to be formally proven. Moreover, many of these murine fate-mapping systems label only a small fraction of the cells per population, rendering functional studies difficult. In cases where classification as cDC1, cDC2, pDC, MC, or M&#x003a6; is not obvious, a core set of signature genes that are specific for each cell type could facilitate correct Level1 identification. However, such signature genes are not easily identified. In addition, identification based on surface receptors would be most practical since it would allow the sorting of living cells through flow cytometry for functional assays. Ideally, such markers would be conserved across species. We are currently data-mining the gene-expression profiles of cells from various tissues and species to try to identify such markers. This can however represent a catch22. To find markers specifically expressed by the different populations, one requires pure gene-expression profiles, but correct sorting of the cells without contamination by other populations for RNA profiling requires the very markers we are looking for. Recent technological advances in single-cell RNA sequencing will allow to profile the gene expression of mixed populations. This may at last disentangle mixed myeloid populations and will hopefully provide the field with new markers that can then be validated with the current fate-mapping systems.</p><p>Although the current classification systems should thus be seen as work in progress, we are confident that in the near future better markers will be found which faithfully translate the cellular origin of cells and will form a practical base for the Level1 classification of myeloid cells. The Level2 classification should in our view be kept as flexible as possible to allow researchers to focus on one particular functional attribute of their cells of interest without implying too many additional features that have not been studied. Finally, it is noteworthy that in parallel to our proposition a nomenclature system for M&#x003a6;s was proposed (<xref rid="B106" ref-type="bibr">106</xref>). In this proposition, terms implying functional specialization such as &#x0201c;classically activated macrophages&#x0201d; (pro-inflammatory) or &#x0201c;alternatively activated macrophages&#x0201d; (anti-inflammatory) were replaced by an objective description of how a M&#x003a6; is cultured <italic>in vitro</italic> [e.g., M&#x003a6; (IL-10)] or identified <italic>in vivo</italic> (e.g., &#x0201c;Relma<sup>hi</sup> M&#x003a6;&#x0201d;). Thus, the common core Level1 would be M&#x003a6; and the added description provides the Level2. This and our classification system thus share three important principles: (i) elimination of terms that imply functional specialization as much as possible, (ii) introduction of a fixed Level1 system across species and tissues, and (iii) permitting flexibility through a Level2 system. Irrespective of which system is used to define the Level1 [ontogeny as we propose, or gene-expression profile as proposed by the Dalod group in this issue (<xref rid="B60" ref-type="bibr">60</xref>, <xref rid="B61" ref-type="bibr">61</xref>)], we feel these three principles should be maintained for a future and hopefully definitive classification system.</p></sec><sec id="S10"><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>We thank Bernard Malissen, Hugues Lelouard, Bart Lambrecht, and Katrijn Neyt for the use of unpublished data. MG is supported by a Marie Curie Reintegration grant, an Odysseus grant, and several FWO grants of the Flemish Government. LL is supported by an EMBO long-term fellowship and a Marie Curie intra-European fellowship.</p></ack><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>D</given-names></name></person-group><source>The Hitch Hiker&#x02019;s Guide to the Galaxy</source>. <publisher-loc>London</publisher-loc>: <publisher-name>Pan Books</publisher-name> (<year>1979</year>).</mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Furth</surname><given-names>R</given-names></name><name><surname>Cohn</surname><given-names>ZA</given-names></name><name><surname>Hirsch</surname><given-names>JG</given-names></name><name><surname>Humphrey</surname><given-names>JH</given-names></name><name><surname>Spector</surname><given-names>WG</given-names></name><name><surname>Langevoort</surname><given-names>HL</given-names></name></person-group>
<article-title>[Mononuclear phagocytic system: new classification of macrophages, monocytes and of their cell line]</article-title>. <source>Bull World Health Organ</source> (<year>1972</year>) <volume>47</volume>:<fpage>651</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">4540685</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>van Furth</surname><given-names>R</given-names></name></person-group>
<article-title>&#x0201c;Identification of Mononuclear Phagocytes: Overview and Definitions,&#x0201d;</article-title> in <source>Methods for Studying Mononuclear Phagocytes</source>. <publisher-loc>London</publisher-loc>: <publisher-name>Academic Press</publisher-name> (<year>1980</year>). p. <fpage>243</fpage>&#x02013;<lpage>52</lpage>.</mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inaba</surname><given-names>K</given-names></name><name><surname>Inaba</surname><given-names>M</given-names></name><name><surname>Romani</surname><given-names>N</given-names></name><name><surname>Aya</surname><given-names>H</given-names></name><name><surname>Deguchi</surname><given-names>M</given-names></name><name><surname>Ikehara</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor</article-title>. <source>J Exp Med</source> (<year>1992</year>) <volume>176</volume>:<fpage>1693</fpage>&#x02013;<lpage>702</lpage>.<pub-id pub-id-type="doi">10.1084/jem.176.6.1693</pub-id><?supplied-pmid 1460426?><pub-id pub-id-type="pmid">1460426</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sallusto</surname><given-names>F</given-names></name><name><surname>Lanzavecchia</surname><given-names>A</given-names></name></person-group>. <article-title>Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha</article-title>. <source>J Exp Med</source> (<year>1994</year>) <volume>179</volume>:<fpage>1109</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="doi">10.1084/jem.179.4.1109</pub-id><?supplied-pmid 8145033?><pub-id pub-id-type="pmid">8145033</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caux</surname><given-names>C</given-names></name><name><surname>Vanbervliet</surname><given-names>B</given-names></name><name><surname>Massacrier</surname><given-names>C</given-names></name><name><surname>Dezutter-Dambuyant</surname><given-names>C</given-names></name><name><surname>De Saint-Vis</surname><given-names>B</given-names></name><name><surname>Jacquet</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha</article-title>. <source>J Exp Med</source> (<year>1996</year>) <volume>184</volume>:<fpage>695</fpage>&#x02013;<lpage>706</lpage>.<pub-id pub-id-type="doi">10.1084/jem.184.2.695</pub-id><?supplied-pmid 8760823?><pub-id pub-id-type="pmid">8760823</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palucka</surname><given-names>KA</given-names></name><name><surname>Taquet</surname><given-names>N</given-names></name><name><surname>Sanchez-Chapuis</surname><given-names>F</given-names></name><name><surname>Gluckman</surname><given-names>JC</given-names></name></person-group>. <article-title>Dendritic cells as the terminal stage of monocyte differentiation</article-title>. <source>J Immunol</source> (<year>1998</year>) <volume>160</volume>:<fpage>4587</fpage>&#x02013;<lpage>95</lpage>.<?supplied-pmid 9574566?><pub-id pub-id-type="pmid">9574566</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Zhan</surname><given-names>Y</given-names></name><name><surname>Lew</surname><given-names>AM</given-names></name><name><surname>Naik</surname><given-names>SH</given-names></name><name><surname>Kershaw</surname><given-names>MH</given-names></name></person-group>. <article-title>Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>179</volume>:<fpage>7577</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.179.11.7577</pub-id><?supplied-pmid 18025203?><pub-id pub-id-type="pmid">18025203</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Randolph</surname><given-names>GJ</given-names></name><name><surname>Inaba</surname><given-names>K</given-names></name><name><surname>Robbiani</surname><given-names>DF</given-names></name><name><surname>Steinman</surname><given-names>RM</given-names></name><name><surname>Muller</surname><given-names>WA</given-names></name></person-group>. <article-title>Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo</article-title>. <source>Immunity</source> (<year>1999</year>) <volume>11</volume>:<fpage>753</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1016/S1074-7613(00)80149-1</pub-id><?supplied-pmid 10626897?><pub-id pub-id-type="pmid">10626897</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geissmann</surname><given-names>F</given-names></name><name><surname>Jung</surname><given-names>S</given-names></name><name><surname>Littman</surname><given-names>DR</given-names></name></person-group>. <article-title>Blood monocytes consist of two principal subsets with distinct migratory properties</article-title>. <source>Immunity</source> (<year>2003</year>) <volume>19</volume>:<fpage>71</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1016/S1074-7613(03)00174-2</pub-id><?supplied-pmid 12871640?><pub-id pub-id-type="pmid">12871640</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serbina</surname><given-names>NV</given-names></name><name><surname>Salazar-Mather</surname><given-names>TP</given-names></name><name><surname>Biron</surname><given-names>CA</given-names></name><name><surname>Kuziel</surname><given-names>WA</given-names></name><name><surname>Pamer</surname><given-names>EG</given-names></name></person-group>. <article-title>TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection</article-title>. <source>Immunity</source> (<year>2003</year>) <volume>19</volume>:<fpage>59</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1016/S1074-7613(03)00171-7</pub-id><?supplied-pmid 12871639?><pub-id pub-id-type="pmid">12871639</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naik</surname><given-names>SH</given-names></name><name><surname>Metcalf</surname><given-names>D</given-names></name><name><surname>Van Nieuwenhuijze</surname><given-names>A</given-names></name><name><surname>Wicks</surname><given-names>I</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>O&#x02019;Keeffe</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes</article-title>. <source>Nat Immunol</source> (<year>2006</year>) <volume>7</volume>:<fpage>663</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1038/ni1340</pub-id><?supplied-pmid 16680143?><pub-id pub-id-type="pmid">16680143</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varol</surname><given-names>C</given-names></name><name><surname>Landsman</surname><given-names>L</given-names></name><name><surname>Fogg</surname><given-names>DK</given-names></name><name><surname>Greenshtein</surname><given-names>L</given-names></name><name><surname>Gildor</surname><given-names>B</given-names></name><name><surname>Margalit</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Monocytes give rise to mucosal, but not splenic, conventional dendritic cells</article-title>. <source>J Exp Med</source> (<year>2007</year>) <volume>204</volume>:<fpage>171</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20061011</pub-id><?supplied-pmid 17190836?><pub-id pub-id-type="pmid">17190836</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogunovic</surname><given-names>M</given-names></name><name><surname>Ginhoux</surname><given-names>F</given-names></name><name><surname>Helft</surname><given-names>J</given-names></name><name><surname>Shang</surname><given-names>L</given-names></name><name><surname>Hashimoto</surname><given-names>D</given-names></name><name><surname>Greter</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Origin of the lamina propria dendritic cell network</article-title>. <source>Immunity</source> (<year>2009</year>) <volume>31</volume>(<issue>3</issue>):<fpage>513</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2009.08.010</pub-id><?supplied-pmid 19733489?><pub-id pub-id-type="pmid">19733489</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varol</surname><given-names>C</given-names></name><name><surname>Vallon-Eberhard</surname><given-names>A</given-names></name><name><surname>Elinav</surname><given-names>E</given-names></name><name><surname>Aychek</surname><given-names>T</given-names></name><name><surname>Shapira</surname><given-names>Y</given-names></name><name><surname>Luche</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Intestinal lamina propria dendritic cell subsets have different origin and functions</article-title>. <source>Immunity</source> (<year>2009</year>) <volume>31</volume>:<fpage>502</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2009.06.025</pub-id><?supplied-pmid 19733097?><pub-id pub-id-type="pmid">19733097</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yona</surname><given-names>S</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name></person-group>. <article-title>From the reticulo-endothelial to mononuclear phagocyte system &#x02013; the unaccounted years</article-title>. <source>Front Immunol</source> (<year>2015</year>) <volume>6</volume>:<fpage>328</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2015.00328</pub-id><?supplied-pmid 26191061?><pub-id pub-id-type="pmid">26191061</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diao</surname><given-names>J</given-names></name><name><surname>Winter</surname><given-names>E</given-names></name><name><surname>Cantin</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Kelvin</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>In situ replication of immediate dendritic cell (DC) precursors contributes to conventional DC homeostasis in lymphoid tissue</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>176</volume>:<fpage>7196</fpage>&#x02013;<lpage>206</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.176.12.7196</pub-id><?supplied-pmid 16751363?><pub-id pub-id-type="pmid">16751363</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naik</surname><given-names>SH</given-names></name><name><surname>Sathe</surname><given-names>P</given-names></name><name><surname>Park</surname><given-names>HY</given-names></name><name><surname>Metcalf</surname><given-names>D</given-names></name><name><surname>Proietto</surname><given-names>AI</given-names></name><name><surname>Dakic</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo</article-title>. <source>Nat Immunol</source> (<year>2007</year>) <volume>8</volume>:<fpage>1217</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1038/ni1522</pub-id><?supplied-pmid 17922015?><pub-id pub-id-type="pmid">17922015</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onai</surname><given-names>N</given-names></name><name><surname>Obata-Onai</surname><given-names>A</given-names></name><name><surname>Schmid</surname><given-names>MA</given-names></name><name><surname>Ohteki</surname><given-names>T</given-names></name><name><surname>Jarrossay</surname><given-names>D</given-names></name><name><surname>Manz</surname><given-names>MG</given-names></name></person-group>. <article-title>Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow</article-title>. <source>Nat Immunol</source> (<year>2007</year>) <volume>8</volume>:<fpage>1207</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1038/ni1518</pub-id><?supplied-pmid 17922016?><pub-id pub-id-type="pmid">17922016</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merad</surname><given-names>M</given-names></name><name><surname>Sathe</surname><given-names>P</given-names></name><name><surname>Helft</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>J</given-names></name><name><surname>Mortha</surname><given-names>A</given-names></name></person-group>. <article-title>The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting</article-title>. <source>Annu Rev Immunol</source> (<year>2013</year>) <volume>31</volume>:<fpage>563</fpage>&#x02013;<lpage>604</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-immunol-020711-074950</pub-id><?supplied-pmid 23516985?><pub-id pub-id-type="pmid">23516985</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saunders</surname><given-names>D</given-names></name><name><surname>Lucas</surname><given-names>K</given-names></name><name><surname>Ismaili</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Maraskovsky</surname><given-names>E</given-names></name><name><surname>Dunn</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte/macrophage colony-stimulating factor</article-title>. <source>J Exp Med</source> (<year>1996</year>) <volume>184</volume>:<fpage>2185</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="doi">10.1084/jem.184.6.2185</pub-id><?supplied-pmid 8976174?><pub-id pub-id-type="pmid">8976174</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pulendran</surname><given-names>B</given-names></name><name><surname>Banchereau</surname><given-names>J</given-names></name><name><surname>Burkeholder</surname><given-names>S</given-names></name><name><surname>Kraus</surname><given-names>E</given-names></name><name><surname>Guinet</surname><given-names>E</given-names></name><name><surname>Chalouni</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo</article-title>. <source>J Immunol</source> (<year>2000</year>) <volume>165</volume>:<fpage>566</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.165.1.566</pub-id><?supplied-pmid 10861097?><pub-id pub-id-type="pmid">10861097</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naik</surname><given-names>SH</given-names></name><name><surname>Proietto</surname><given-names>AI</given-names></name><name><surname>Wilson</surname><given-names>NS</given-names></name><name><surname>Dakic</surname><given-names>A</given-names></name><name><surname>Schnorrer</surname><given-names>P</given-names></name><name><surname>Fuchsberger</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures</article-title>. <source>J Immunol</source> (<year>2005</year>) <volume>174</volume>:<fpage>6592</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.174.11.6592</pub-id><?supplied-pmid 15905497?><pub-id pub-id-type="pmid">15905497</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salomon</surname><given-names>B</given-names></name><name><surname>Cohen</surname><given-names>JL</given-names></name><name><surname>Masurier</surname><given-names>C</given-names></name><name><surname>Klatzmann</surname><given-names>D</given-names></name></person-group>. <article-title>Three populations of mouse lymph node dendritic cells with different origins and dynamics</article-title>. <source>J Immunol</source> (<year>1998</year>) <volume>160</volume>:<fpage>708</fpage>&#x02013;<lpage>17</lpage>.<?supplied-pmid 9551906?><pub-id pub-id-type="pmid">9551906</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKenna</surname><given-names>HJ</given-names></name><name><surname>Stocking</surname><given-names>KL</given-names></name><name><surname>Miller</surname><given-names>RE</given-names></name><name><surname>Brasel</surname><given-names>K</given-names></name><name><surname>De Smedt</surname><given-names>T</given-names></name><name><surname>Maraskovsky</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells</article-title>. <source>Blood</source> (<year>2000</year>) <volume>95</volume>:<fpage>3489</fpage>&#x02013;<lpage>97</lpage>.<?supplied-pmid 10828034?><pub-id pub-id-type="pmid">10828034</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karsunky</surname><given-names>H</given-names></name><name><surname>Merad</surname><given-names>M</given-names></name><name><surname>Cozzio</surname><given-names>A</given-names></name><name><surname>Weissman</surname><given-names>IL</given-names></name><name><surname>Manz</surname><given-names>MG</given-names></name></person-group>. <article-title>Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo</article-title>. <source>J Exp Med</source> (<year>2003</year>) <volume>198</volume>:<fpage>305</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20030323</pub-id><?supplied-pmid 12874263?><pub-id pub-id-type="pmid">12874263</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waskow</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Darrasse-Jeze</surname><given-names>G</given-names></name><name><surname>Guermonprez</surname><given-names>P</given-names></name><name><surname>Ginhoux</surname><given-names>F</given-names></name><name><surname>Merad</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues</article-title>. <source>Nat Immunol</source> (<year>2008</year>) <volume>9</volume>:<fpage>676</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1038/ni.1615</pub-id><?supplied-pmid 18469816?><pub-id pub-id-type="pmid">18469816</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginhoux</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Helft</surname><given-names>J</given-names></name><name><surname>Bogunovic</surname><given-names>M</given-names></name><name><surname>Greter</surname><given-names>M</given-names></name><name><surname>Hashimoto</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>The origin and development of nonlymphoid tissue CD103+ DCs</article-title>. <source>J Exp Med</source> (<year>2009</year>) <volume>206</volume>:<fpage>3115</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20091756</pub-id><?supplied-pmid 20008528?><pub-id pub-id-type="pmid">20008528</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onai</surname><given-names>N</given-names></name><name><surname>Kurabayashi</surname><given-names>K</given-names></name><name><surname>Hosoi-Amaike</surname><given-names>M</given-names></name><name><surname>Toyama-Sorimachi</surname><given-names>N</given-names></name><name><surname>Matsushima</surname><given-names>K</given-names></name><name><surname>Inaba</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>A clonogenic progenitor with prominent plasmacytoid dendritic cell developmental potential</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>38</volume>:<fpage>943</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2013.04.006</pub-id><?supplied-pmid 23623382?><pub-id pub-id-type="pmid">23623382</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hettinger</surname><given-names>J</given-names></name><name><surname>Richards</surname><given-names>DM</given-names></name><name><surname>Hansson</surname><given-names>J</given-names></name><name><surname>Barra</surname><given-names>MM</given-names></name><name><surname>Joschko</surname><given-names>AC</given-names></name><name><surname>Krijgsveld</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Origin of monocytes and macrophages in a committed progenitor</article-title>. <source>Nat Immunol</source> (<year>2013</year>) <volume>14</volume>:<fpage>821</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2638</pub-id><?supplied-pmid 23812096?><pub-id pub-id-type="pmid">23812096</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breton</surname><given-names>G</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>YJ</given-names></name><name><surname>Schreiber</surname><given-names>JJ</given-names></name><name><surname>Keler</surname><given-names>T</given-names></name><name><surname>Puhr</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Circulating precursors of human CD1c+ and CD141+ dendritic cells</article-title>. <source>J Exp Med</source> (<year>2015</year>) <volume>212</volume>:<fpage>401</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20141441</pub-id><?supplied-pmid 25687281?><pub-id pub-id-type="pmid">25687281</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Breton</surname><given-names>G</given-names></name><name><surname>Oliveira</surname><given-names>TY</given-names></name><name><surname>Zhou</surname><given-names>YJ</given-names></name><name><surname>Aljoufi</surname><given-names>A</given-names></name><name><surname>Puhr</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow</article-title>. <source>J Exp Med</source> (<year>2015</year>) <volume>212</volume>:<fpage>385</fpage>&#x02013;<lpage>99</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20141442</pub-id><?supplied-pmid 25687283?><pub-id pub-id-type="pmid">25687283</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginhoux</surname><given-names>F</given-names></name><name><surname>Greter</surname><given-names>M</given-names></name><name><surname>Leboeuf</surname><given-names>M</given-names></name><name><surname>Nandi</surname><given-names>S</given-names></name><name><surname>See</surname><given-names>P</given-names></name><name><surname>Gokhan</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Fate mapping analysis reveals that adult microglia derive from primitive macrophages</article-title>. <source>Science</source> (<year>2010</year>) <volume>330</volume>:<fpage>841</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1126/science.1194637</pub-id><?supplied-pmid 20966214?><pub-id pub-id-type="pmid">20966214</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname><given-names>C</given-names></name><name><surname>Gomez Perdiguero</surname><given-names>E</given-names></name><name><surname>Chorro</surname><given-names>L</given-names></name><name><surname>Szabo-Rogers</surname><given-names>H</given-names></name><name><surname>Cagnard</surname><given-names>N</given-names></name><name><surname>Kierdorf</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>A lineage of myeloid cells independent of Myb and hematopoietic stem cells</article-title>. <source>Science</source> (<year>2012</year>) <volume>336</volume>:<fpage>86</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1126/science.1219179</pub-id><?supplied-pmid 22442384?><pub-id pub-id-type="pmid">22442384</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guilliams</surname><given-names>M</given-names></name><name><surname>De Kleer</surname><given-names>I</given-names></name><name><surname>Henri</surname><given-names>S</given-names></name><name><surname>Post</surname><given-names>S</given-names></name><name><surname>Vanhoutte</surname><given-names>L</given-names></name><name><surname>De Prijck</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF</article-title>. <source>J Exp Med</source> (<year>2013</year>) <volume>210</volume>:<fpage>1977</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20131199</pub-id><?supplied-pmid 24043763?><pub-id pub-id-type="pmid">24043763</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>D</given-names></name><name><surname>Chow</surname><given-names>A</given-names></name><name><surname>Noizat</surname><given-names>C</given-names></name><name><surname>Teo</surname><given-names>P</given-names></name><name><surname>Beasley</surname><given-names>MB</given-names></name><name><surname>Leboeuf</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>38</volume>:<fpage>792</fpage>&#x02013;<lpage>804</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2013.04.004</pub-id><?supplied-pmid 23601688?><pub-id pub-id-type="pmid">23601688</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakubzick</surname><given-names>C</given-names></name><name><surname>Gautier</surname><given-names>EL</given-names></name><name><surname>Gibbings</surname><given-names>SL</given-names></name><name><surname>Sojka</surname><given-names>DK</given-names></name><name><surname>Schlitzer</surname><given-names>A</given-names></name><name><surname>Johnson</surname><given-names>TE</given-names></name><etal/></person-group>
<article-title>Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>39</volume>:<fpage>599</fpage>&#x02013;<lpage>610</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2013.08.007</pub-id><?supplied-pmid 24012416?><pub-id pub-id-type="pmid">24012416</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yona</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>KW</given-names></name><name><surname>Wolf</surname><given-names>Y</given-names></name><name><surname>Mildner</surname><given-names>A</given-names></name><name><surname>Varol</surname><given-names>D</given-names></name><name><surname>Breker</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>38</volume>:<fpage>79</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2012.12.001</pub-id><?supplied-pmid 23273845?><pub-id pub-id-type="pmid">23273845</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez Perdiguero</surname><given-names>E</given-names></name><name><surname>Klapproth</surname><given-names>K</given-names></name><name><surname>Schulz</surname><given-names>C</given-names></name><name><surname>Busch</surname><given-names>K</given-names></name><name><surname>Azzoni</surname><given-names>E</given-names></name><name><surname>Crozet</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors</article-title>. <source>Nature</source> (<year>2015</year>) <volume>518</volume>:<fpage>547</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1038/nature13989</pub-id><?supplied-pmid 25470051?><pub-id pub-id-type="pmid">25470051</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginhoux</surname><given-names>F</given-names></name><name><surname>Jung</surname><given-names>S</given-names></name></person-group>. <article-title>Monocytes and macrophages: developmental pathways and tissue homeostasis</article-title>. <source>Nat Rev Immunol</source> (<year>2014</year>) <volume>14</volume>:<fpage>392</fpage>&#x02013;<lpage>404</lpage>.<pub-id pub-id-type="doi">10.1038/nri3671</pub-id><?supplied-pmid 24854589?><pub-id pub-id-type="pmid">24854589</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>CL</given-names></name><name><surname>Henri</surname><given-names>S</given-names></name><name><surname>Guilliams</surname><given-names>M</given-names></name></person-group>. <article-title>Mononuclear phagocytes of the intestine, the skin, and the lung</article-title>. <source>Immunol Rev</source> (<year>2014</year>) <volume>262</volume>:<fpage>9</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1111/imr.12220</pub-id><?supplied-pmid 25319324?><pub-id pub-id-type="pmid">25319324</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varol</surname><given-names>C</given-names></name><name><surname>Mildner</surname><given-names>A</given-names></name><name><surname>Jung</surname><given-names>S</given-names></name></person-group>. <article-title>Macrophages: development and tissue specialization</article-title>. <source>Annu Rev Immunol</source> (<year>2015</year>) <volume>33</volume>:<fpage>643</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-immunol-032414-112220</pub-id><?supplied-pmid 25861979?><pub-id pub-id-type="pmid">25861979</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoeffel</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Greter</surname><given-names>M</given-names></name><name><surname>See</surname><given-names>P</given-names></name><name><surname>Teo</surname><given-names>P</given-names></name><name><surname>Malleret</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages</article-title>. <source>J Exp Med</source> (<year>2012</year>) <volume>209</volume>(<issue>6</issue>):<fpage>1167</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20120340</pub-id><?supplied-pmid 22565823?><pub-id pub-id-type="pmid">22565823</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoeffel</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Lavin</surname><given-names>Y</given-names></name><name><surname>Low</surname><given-names>D</given-names></name><name><surname>Almeida</surname><given-names>FF</given-names></name><name><surname>See</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>C-myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages</article-title>. <source>Immunity</source> (<year>2015</year>) <volume>42</volume>:<fpage>665</fpage>&#x02013;<lpage>78</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2015.03.011</pub-id><?supplied-pmid 25902481?><pub-id pub-id-type="pmid">25902481</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamoutounour</surname><given-names>S</given-names></name><name><surname>Henri</surname><given-names>S</given-names></name><name><surname>Lelouard</surname><given-names>H</given-names></name><name><surname>De Bovis</surname><given-names>B</given-names></name><name><surname>De Haar</surname><given-names>C</given-names></name><name><surname>Van Der Woude</surname><given-names>CJ</given-names></name><etal/></person-group>
<article-title>CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis</article-title>. <source>Eur J Immunol</source> (<year>2012</year>) <volume>42</volume>(<issue>12</issue>):<fpage>3150</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201242847</pub-id><?supplied-pmid 22936024?><pub-id pub-id-type="pmid">22936024</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bain</surname><given-names>CC</given-names></name><name><surname>Scott</surname><given-names>CL</given-names></name><name><surname>Uronen-Hansson</surname><given-names>H</given-names></name><name><surname>Gudjonsson</surname><given-names>S</given-names></name><name><surname>Jansson</surname><given-names>O</given-names></name><name><surname>Grip</surname><given-names>O</given-names></name><etal/></person-group>
<article-title>Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6C(hi) monocyte precursors</article-title>. <source>Mucosal Immunol</source> (<year>2012</year>) <volume>6</volume>(<issue>3</issue>):<fpage>498</fpage>&#x02013;<lpage>510</lpage>.<pub-id pub-id-type="doi">10.1038/mi.2012.89</pub-id><?supplied-pmid 22990622?><pub-id pub-id-type="pmid">22990622</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plantinga</surname><given-names>M</given-names></name><name><surname>Guilliams</surname><given-names>M</given-names></name><name><surname>Vanheerswynghels</surname><given-names>M</given-names></name><name><surname>Deswarte</surname><given-names>K</given-names></name><name><surname>Branco-Madeira</surname><given-names>F</given-names></name><name><surname>Toussaint</surname><given-names>W</given-names></name><etal/></person-group>
<article-title>Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>38</volume>:<fpage>322</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2012.10.016</pub-id><?supplied-pmid 23352232?><pub-id pub-id-type="pmid">23352232</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamoutounour</surname><given-names>S</given-names></name><name><surname>Guilliams</surname><given-names>M</given-names></name><name><surname>Montanana Sanchis</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Terhorst</surname><given-names>D</given-names></name><name><surname>Malosse</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>39</volume>:<fpage>925</fpage>&#x02013;<lpage>38</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2013.10.004</pub-id><?supplied-pmid 24184057?><pub-id pub-id-type="pmid">24184057</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geurtsvankessel</surname><given-names>CH</given-names></name><name><surname>Bergen</surname><given-names>IM</given-names></name><name><surname>Muskens</surname><given-names>F</given-names></name><name><surname>Boon</surname><given-names>L</given-names></name><name><surname>Hoogsteden</surname><given-names>HC</given-names></name><name><surname>Osterhaus</surname><given-names>AD</given-names></name><etal/></person-group>
<article-title>Both conventional and interferon killer dendritic cells have antigen-presenting capacity during influenza virus infection</article-title>. <source>PLoS One</source> (<year>2009</year>) <volume>4</volume>:<fpage>e7187</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0007187</pub-id><?supplied-pmid 19784375?><pub-id pub-id-type="pmid">19784375</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janssen</surname><given-names>WJ</given-names></name><name><surname>Barthel</surname><given-names>L</given-names></name><name><surname>Muldrow</surname><given-names>A</given-names></name><name><surname>Oberley-Deegan</surname><given-names>RE</given-names></name><name><surname>Kearns</surname><given-names>MT</given-names></name><name><surname>Jakubzick</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2011</year>) <volume>184</volume>:<fpage>547</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.201011-1891OC</pub-id><?supplied-pmid 21471090?><pub-id pub-id-type="pmid">21471090</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balan</surname><given-names>S</given-names></name><name><surname>Ollion</surname><given-names>V</given-names></name><name><surname>Colletti</surname><given-names>N</given-names></name><name><surname>Chelbi</surname><given-names>R</given-names></name><name><surname>Montanana-Sanchis</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>193</volume>:<fpage>1622</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1401243</pub-id><?supplied-pmid 25009205?><pub-id pub-id-type="pmid">25009205</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desch</surname><given-names>AN</given-names></name><name><surname>Gibbings</surname><given-names>SL</given-names></name><name><surname>Clambey</surname><given-names>ET</given-names></name><name><surname>Janssen</surname><given-names>WJ</given-names></name><name><surname>Slansky</surname><given-names>JE</given-names></name><name><surname>Kedl</surname><given-names>RM</given-names></name><etal/></person-group>
<article-title>Dendritic cell subsets require cis-activation for cytotoxic CD8 T-cell induction</article-title>. <source>Nat Commun</source> (<year>2014</year>) <volume>5</volume>:<fpage>4674</fpage>.<pub-id pub-id-type="doi">10.1038/ncomms5674</pub-id><?supplied-pmid 25135627?><pub-id pub-id-type="pmid">25135627</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guilliams</surname><given-names>M</given-names></name><name><surname>Ginhoux</surname><given-names>F</given-names></name><name><surname>Jakubzick</surname><given-names>C</given-names></name><name><surname>Naik</surname><given-names>SH</given-names></name><name><surname>Onai</surname><given-names>N</given-names></name><name><surname>Schraml</surname><given-names>BU</given-names></name><etal/></person-group>
<article-title>Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny</article-title>. <source>Nat Rev Immunol</source> (<year>2014</year>) <volume>14</volume>:<fpage>571</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/nri3712</pub-id><?supplied-pmid 25033907?><pub-id pub-id-type="pmid">25033907</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>J</given-names></name><name><surname>Schmidt</surname><given-names>SV</given-names></name><name><surname>Sander</surname><given-names>J</given-names></name><name><surname>Draffehn</surname><given-names>A</given-names></name><name><surname>Krebs</surname><given-names>W</given-names></name><name><surname>Quester</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>Transcriptome-based network analysis reveals a spectrum model of human macrophage activation</article-title>. <source>Immunity</source> (<year>2014</year>) <volume>40</volume>:<fpage>274</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2014.01.006</pub-id><?supplied-pmid 24530056?><pub-id pub-id-type="pmid">24530056</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robbins</surname><given-names>SH</given-names></name><name><surname>Walzer</surname><given-names>T</given-names></name><name><surname>Dembele</surname><given-names>D</given-names></name><name><surname>Thibault</surname><given-names>C</given-names></name><name><surname>Defays</surname><given-names>A</given-names></name><name><surname>Bessou</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling</article-title>. <source>Genome Biol</source> (<year>2008</year>) <volume>9</volume>:<fpage>R17</fpage>.<pub-id pub-id-type="doi">10.1186/gb-2008-9-1-r17</pub-id><?supplied-pmid 18218067?><pub-id pub-id-type="pmid">18218067</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crozat</surname><given-names>K</given-names></name><name><surname>Guiton</surname><given-names>R</given-names></name><name><surname>Guilliams</surname><given-names>M</given-names></name><name><surname>Henri</surname><given-names>S</given-names></name><name><surname>Baranek</surname><given-names>T</given-names></name><name><surname>Schwartz-Cornil</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>Comparative genomics as a tool to reveal functional equivalences between human and mouse dendritic cell subsets</article-title>. <source>Immunol Rev</source> (<year>2010</year>) <volume>234</volume>:<fpage>177</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="doi">10.1111/j.0105-2896.2009.00868.x</pub-id><?supplied-pmid 20193019?><pub-id pub-id-type="pmid">20193019</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guilliams</surname><given-names>M</given-names></name><name><surname>Henri</surname><given-names>S</given-names></name><name><surname>Tamoutounour</surname><given-names>S</given-names></name><name><surname>Ardouin</surname><given-names>L</given-names></name><name><surname>Schwartz-Cornil</surname><given-names>I</given-names></name><name><surname>Dalod</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>From skin dendritic cells to a simplified classification of human and mouse dendritic cell subsets</article-title>. <source>Eur J Immunol</source> (<year>2010</year>) <volume>40</volume>:<fpage>2089</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201040498</pub-id><?supplied-pmid 20853491?><pub-id pub-id-type="pmid">20853491</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>MA</given-names></name><name><surname>Feng</surname><given-names>XJ</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Rabitz</surname><given-names>HA</given-names></name></person-group>. <article-title>Identifying biological network structure, predicting network behavior, and classifying network state with high dimensional model representation (HDMR)</article-title>. <source>PLoS One</source> (<year>2012</year>) <volume>7</volume>:<fpage>e37664</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0037664</pub-id><?supplied-pmid 22723838?><pub-id pub-id-type="pmid">22723838</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vu Manh</surname><given-names>TP</given-names></name><name><surname>Marty</surname><given-names>H</given-names></name><name><surname>Sibille</surname><given-names>P</given-names></name><name><surname>Le Vern</surname><given-names>Y</given-names></name><name><surname>Kaspers</surname><given-names>B</given-names></name><name><surname>Dalod</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Existence of conventional dendritic cells in gallus gallus revealed by comparative gene expression profiling</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>192</volume>(<issue>10</issue>):<fpage>4510</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1303405</pub-id><?supplied-pmid 24740508?><pub-id pub-id-type="pmid">24740508</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vu Manh</surname><given-names>TP</given-names></name><name><surname>Bertho</surname><given-names>N</given-names></name><name><surname>Hosmalin</surname><given-names>A</given-names></name><name><surname>Schwartz-Cornil</surname><given-names>I</given-names></name><name><surname>Dalod</surname><given-names>M</given-names></name></person-group>. <article-title>Investigating evolutionary conservation of dendritic cell subset identity and functions</article-title>. <source>Front Immunol</source> (<year>2015</year>) <volume>6</volume>:<fpage>260</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2015.00260</pub-id><?supplied-pmid 26082777?><pub-id pub-id-type="pmid">26082777</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vu Manh</surname><given-names>TP</given-names></name><name><surname>Elhmouzi-Younes</surname><given-names>J</given-names></name><name><surname>Urien</surname><given-names>C</given-names></name><name><surname>Ruscanu</surname><given-names>S</given-names></name><name><surname>Jouneau</surname><given-names>L</given-names></name><name><surname>Bourge</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Defining mononuclear phagocyte subset homology across several distant warm-blooded vertebrates through comparative transcriptomics</article-title>. <source>Front Immunol</source> (<year>2015</year>) <volume>6</volume>:<fpage>299</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2015.00299</pub-id><?supplied-pmid 26150816?><pub-id pub-id-type="pmid">26150816</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durand</surname><given-names>M</given-names></name><name><surname>Segura</surname><given-names>E</given-names></name></person-group>. <article-title>The known unknowns of the human dendritic cell network</article-title>. <source>Front Immunol</source> (<year>2015</year>) <volume>6</volume>:<fpage>129</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2015.00129</pub-id><?supplied-pmid 25852695?><pub-id pub-id-type="pmid">25852695</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>G</given-names></name><name><surname>Haniffa</surname><given-names>M</given-names></name></person-group>. <article-title>Human and mouse mononuclear phagocyte networks: a tale of two species?</article-title>
<source>Front Immunol</source> (<year>2015</year>) <volume>6</volume>:<fpage>330</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2015.00330</pub-id><?supplied-pmid 26124761?><pub-id pub-id-type="pmid">26124761</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bachem</surname><given-names>A</given-names></name><name><surname>Guttler</surname><given-names>S</given-names></name><name><surname>Hartung</surname><given-names>E</given-names></name><name><surname>Ebstein</surname><given-names>F</given-names></name><name><surname>Schaefer</surname><given-names>M</given-names></name><name><surname>Tannert</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells</article-title>. <source>J Exp Med</source> (<year>2010</year>) <volume>207</volume>:<fpage>1273</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20100348</pub-id><?supplied-pmid 20479115?><pub-id pub-id-type="pmid">20479115</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Contreras</surname><given-names>V</given-names></name><name><surname>Urien</surname><given-names>C</given-names></name><name><surname>Guiton</surname><given-names>R</given-names></name><name><surname>Alexandre</surname><given-names>Y</given-names></name><name><surname>Vu Manh</surname><given-names>TP</given-names></name><name><surname>Andrieu</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Existence of CD8alpha-like dendritic cells with a conserved functional specialization and a common molecular signature in distant mammalian species</article-title>. <source>J Immunol</source> (<year>2010</year>) <volume>185</volume>:<fpage>3313</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1000824</pub-id><?supplied-pmid 20702727?><pub-id pub-id-type="pmid">20702727</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crozat</surname><given-names>K</given-names></name><name><surname>Guiton</surname><given-names>R</given-names></name><name><surname>Contreras</surname><given-names>V</given-names></name><name><surname>Feuillet</surname><given-names>V</given-names></name><name><surname>Dutertre</surname><given-names>CA</given-names></name><name><surname>Ventre</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells</article-title>. <source>J Exp Med</source> (<year>2010</year>) <volume>207</volume>:<fpage>1283</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20100223</pub-id><?supplied-pmid 20479118?><pub-id pub-id-type="pmid">20479118</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crozat</surname><given-names>K</given-names></name><name><surname>Tamoutounour</surname><given-names>S</given-names></name><name><surname>Vu Manh</surname><given-names>TP</given-names></name><name><surname>Fossum</surname><given-names>E</given-names></name><name><surname>Luche</surname><given-names>H</given-names></name><name><surname>Ardouin</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Cutting edge: expression of XCR1 defines mouse lymphoid-tissue resident and migratory dendritic cells of the CD8alpha+ type</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>187</volume>:<fpage>4411</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1101717</pub-id><?supplied-pmid 21948982?><pub-id pub-id-type="pmid">21948982</pub-id></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bachem</surname><given-names>A</given-names></name><name><surname>Hartung</surname><given-names>E</given-names></name><name><surname>Guttler</surname><given-names>S</given-names></name><name><surname>Mora</surname><given-names>A</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Hegemann</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Expression of XCR1 characterizes the Batf3-dependent lineage of dendritic cells capable of antigen cross-presentation</article-title>. <source>Front Immunol</source> (<year>2012</year>) <volume>3</volume>:<fpage>214</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2012.00214</pub-id><?supplied-pmid 22826713?><pub-id pub-id-type="pmid">22826713</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>M</given-names></name><name><surname>Guttler</surname><given-names>S</given-names></name><name><surname>Bachem</surname><given-names>A</given-names></name><name><surname>Hartung</surname><given-names>E</given-names></name><name><surname>Mora</surname><given-names>A</given-names></name><name><surname>Jakel</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Ontogenic, phenotypic, and functional characterization of XCR1(+) dendritic cells leads to a consistent classification of intestinal dendritic cells based on the expression of XCR1 and SIRPalpha</article-title>. <source>Front Immunol</source> (<year>2014</year>) <volume>5</volume>:<fpage>326</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2014.00326</pub-id><?supplied-pmid 25120540?><pub-id pub-id-type="pmid">25120540</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurka</surname><given-names>S</given-names></name><name><surname>Hartung</surname><given-names>E</given-names></name><name><surname>Becker</surname><given-names>M</given-names></name><name><surname>Kroczek</surname><given-names>RA</given-names></name></person-group>. <article-title>Mouse conventional dendritic cells can be universally classified based on the mutually exclusive expression of XCR1 and SIRPalpha</article-title>. <source>Front Immunol</source> (<year>2015</year>) <volume>6</volume>:<fpage>35</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2015.00035</pub-id><?supplied-pmid 25699051?><pub-id pub-id-type="pmid">25699051</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grajales-Reyes</surname><given-names>GE</given-names></name><name><surname>Iwata</surname><given-names>A</given-names></name><name><surname>Albring</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Tussiwand</surname><given-names>R</given-names></name><name><surname>Kc</surname><given-names>W</given-names></name><etal/></person-group>
<article-title>Batf3 maintains autoactivation of Irf8 for commitment of a CD8alpha conventional DC clonogenic progenitor</article-title>. <source>Nat Immunol</source> (<year>2015</year>) <volume>16</volume>(<issue>7</issue>):<fpage>708</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="doi">10.1038/ni.3197</pub-id><?supplied-pmid 26054719?><pub-id pub-id-type="pmid">26054719</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlitzer</surname><given-names>A</given-names></name><name><surname>Sivakamasundari</surname><given-names>V</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Sumatoh</surname><given-names>HR</given-names></name><name><surname>Schreuder</surname><given-names>J</given-names></name><name><surname>Lum</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Identification of cDC1- and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow</article-title>. <source>Nat Immunol</source> (<year>2015</year>) <volume>16</volume>(<issue>7</issue>):<fpage>718</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="doi">10.1038/ni.3200</pub-id><?supplied-pmid 26054720?><pub-id pub-id-type="pmid">26054720</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hildner</surname><given-names>K</given-names></name><name><surname>Edelson</surname><given-names>BT</given-names></name><name><surname>Purtha</surname><given-names>WE</given-names></name><name><surname>Diamond</surname><given-names>M</given-names></name><name><surname>Matsushita</surname><given-names>H</given-names></name><name><surname>Kohyama</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity</article-title>. <source>Science</source> (<year>2008</year>) <volume>322</volume>:<fpage>1097</fpage>&#x02013;<lpage>100</lpage>.<pub-id pub-id-type="doi">10.1126/science.1164206</pub-id><?supplied-pmid 19008445?><pub-id pub-id-type="pmid">19008445</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edelson</surname><given-names>BT</given-names></name><name><surname>Kc</surname><given-names>W</given-names></name><name><surname>Juang</surname><given-names>R</given-names></name><name><surname>Kohyama</surname><given-names>M</given-names></name><name><surname>Benoit</surname><given-names>LA</given-names></name><name><surname>Klekotka</surname><given-names>PA</given-names></name><etal/></person-group>
<article-title>Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells</article-title>. <source>J Exp Med</source> (<year>2010</year>) <volume>207</volume>:<fpage>823</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20091627</pub-id><?supplied-pmid 20351058?><pub-id pub-id-type="pmid">20351058</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hacker</surname><given-names>C</given-names></name><name><surname>Kirsch</surname><given-names>RD</given-names></name><name><surname>Ju</surname><given-names>XS</given-names></name><name><surname>Hieronymus</surname><given-names>T</given-names></name><name><surname>Gust</surname><given-names>TC</given-names></name><name><surname>Kuhl</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Transcriptional profiling identifies Id2 function in dendritic cell development</article-title>. <source>Nat Immunol</source> (<year>2003</year>) <volume>4</volume>:<fpage>380</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1038/ni903</pub-id><?supplied-pmid 12598895?><pub-id pub-id-type="pmid">12598895</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>JT</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Masson</surname><given-names>F</given-names></name><name><surname>D&#x02019;Amico</surname><given-names>A</given-names></name><name><surname>Carotta</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Id2 expression delineates differential checkpoints in the genetic program of CD8alpha+ and CD103+ dendritic cell lineages</article-title>. <source>EMBO J</source> (<year>2011</year>) <volume>30</volume>:<fpage>2690</fpage>&#x02013;<lpage>704</lpage>.<pub-id pub-id-type="doi">10.1038/emboj.2011.163</pub-id><?supplied-pmid 21587207?><pub-id pub-id-type="pmid">21587207</pub-id></mixed-citation></ref><ref id="B77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashiwada</surname><given-names>M</given-names></name><name><surname>Pham</surname><given-names>NL</given-names></name><name><surname>Pewe</surname><given-names>LL</given-names></name><name><surname>Harty</surname><given-names>JT</given-names></name><name><surname>Rothman</surname><given-names>PB</given-names></name></person-group>. <article-title>NFIL3/E4BP4 is a key transcription factor for CD8alpha(+) dendritic cell development</article-title>. <source>Blood</source> (<year>2011</year>) <volume>117</volume>:<fpage>6193</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2010-07-295873</pub-id><?supplied-pmid 21474667?><pub-id pub-id-type="pmid">21474667</pub-id></mixed-citation></ref><ref id="B78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiavoni</surname><given-names>G</given-names></name><name><surname>Mattei</surname><given-names>F</given-names></name><name><surname>Sestili</surname><given-names>P</given-names></name><name><surname>Borghi</surname><given-names>P</given-names></name><name><surname>Venditti</surname><given-names>M</given-names></name><name><surname>Morse</surname><given-names>HC</given-names><suffix>III</suffix></name><etal/></person-group>
<article-title>ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells</article-title>. <source>J Exp Med</source> (<year>2002</year>) <volume>196</volume>:<fpage>1415</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20021263</pub-id><?supplied-pmid 12461077?><pub-id pub-id-type="pmid">12461077</pub-id></mixed-citation></ref><ref id="B79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamura</surname><given-names>T</given-names></name><name><surname>Tailor</surname><given-names>P</given-names></name><name><surname>Yamaoka</surname><given-names>K</given-names></name><name><surname>Kong</surname><given-names>HJ</given-names></name><name><surname>Tsujimura</surname><given-names>H</given-names></name><name><surname>O&#x02019;Shea</surname><given-names>JJ</given-names></name><etal/></person-group>
<article-title>IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity</article-title>. <source>J Immunol</source> (<year>2005</year>) <volume>174</volume>:<fpage>2573</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.174.5.2573</pub-id><?supplied-pmid 15728463?><pub-id pub-id-type="pmid">15728463</pub-id></mixed-citation></ref><ref id="B80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tailor</surname><given-names>P</given-names></name><name><surname>Tamura</surname><given-names>T</given-names></name><name><surname>Morse</surname><given-names>HC</given-names><suffix>III</suffix></name><name><surname>Ozato</surname><given-names>K</given-names></name></person-group>. <article-title>The BXH2 mutation in IRF8 differentially impairs dendritic cell subset development in the mouse</article-title>. <source>Blood</source> (<year>2008</year>) <volume>111</volume>:<fpage>1942</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2007-07-100750</pub-id><?supplied-pmid 18055870?><pub-id pub-id-type="pmid">18055870</pub-id></mixed-citation></ref><ref id="B81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>D&#x02019;Amico</surname><given-names>A</given-names></name><name><surname>Winkel</surname><given-names>KD</given-names></name><name><surname>Suter</surname><given-names>M</given-names></name><name><surname>Lo</surname><given-names>D</given-names></name><name><surname>Shortman</surname><given-names>K</given-names></name></person-group>. <article-title>RelB is essential for the development of myeloid-related CD8alpha- dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells</article-title>. <source>Immunity</source> (<year>1998</year>) <volume>9</volume>:<fpage>839</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="doi">10.1016/S1074-7613(00)80649-4</pub-id><?supplied-pmid 9881974?><pub-id pub-id-type="pmid">9881974</pub-id></mixed-citation></ref><ref id="B82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caton</surname><given-names>ML</given-names></name><name><surname>Smith-Raska</surname><given-names>MR</given-names></name><name><surname>Reizis</surname><given-names>B</given-names></name></person-group>. <article-title>Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen</article-title>. <source>J Exp Med</source> (<year>2007</year>) <volume>204</volume>:<fpage>1653</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20062648</pub-id><?supplied-pmid 17591855?><pub-id pub-id-type="pmid">17591855</pub-id></mixed-citation></ref><ref id="B83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>S</given-names></name><name><surname>Honma</surname><given-names>K</given-names></name><name><surname>Matsuyama</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Toriyama</surname><given-names>K</given-names></name><name><surname>Akitoyo</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>Critical roles of interferon regulatory factor 4 in CD11bhighCD8alpha- dendritic cell development</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2004</year>) <volume>101</volume>:<fpage>8981</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0402139101</pub-id><?supplied-pmid 15184678?><pub-id pub-id-type="pmid">15184678</pub-id></mixed-citation></ref><ref id="B84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Persson</surname><given-names>EK</given-names></name><name><surname>Uronen-Hansson</surname><given-names>H</given-names></name><name><surname>Semmrich</surname><given-names>M</given-names></name><name><surname>Rivollier</surname><given-names>A</given-names></name><name><surname>Hagerbrand</surname><given-names>K</given-names></name><name><surname>Marsal</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>IRF4 transcription-factor-dependent CD103CD11b dendritic cells drive mucosal T helper 17 cell differentiation</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>38</volume>(<issue>5</issue>):<fpage>958</fpage>&#x02013;<lpage>69</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2013.03.009</pub-id><?supplied-pmid 23664832?><pub-id pub-id-type="pmid">23664832</pub-id></mixed-citation></ref><ref id="B85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlitzer</surname><given-names>A</given-names></name><name><surname>Mcgovern</surname><given-names>N</given-names></name><name><surname>Teo</surname><given-names>P</given-names></name><name><surname>Zelante</surname><given-names>T</given-names></name><name><surname>Atarashi</surname><given-names>K</given-names></name><name><surname>Low</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>38</volume>:<fpage>970</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2013.04.011</pub-id><?supplied-pmid 23706669?><pub-id pub-id-type="pmid">23706669</pub-id></mixed-citation></ref><ref id="B86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cisse</surname><given-names>B</given-names></name><name><surname>Caton</surname><given-names>ML</given-names></name><name><surname>Lehner</surname><given-names>M</given-names></name><name><surname>Maeda</surname><given-names>T</given-names></name><name><surname>Scheu</surname><given-names>S</given-names></name><name><surname>Locksley</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development</article-title>. <source>Cell</source> (<year>2008</year>) <volume>135</volume>:<fpage>37</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2008.09.016</pub-id><?supplied-pmid 18854153?><pub-id pub-id-type="pmid">18854153</pub-id></mixed-citation></ref><ref id="B87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>HS</given-names></name><name><surname>Cisse</surname><given-names>B</given-names></name><name><surname>Bunin</surname><given-names>A</given-names></name><name><surname>Lewis</surname><given-names>KL</given-names></name><name><surname>Reizis</surname><given-names>B</given-names></name></person-group>. <article-title>Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells</article-title>. <source>Immunity</source> (<year>2010</year>) <volume>33</volume>:<fpage>905</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2010.11.023</pub-id><?supplied-pmid 21145760?><pub-id pub-id-type="pmid">21145760</pub-id></mixed-citation></ref><ref id="B88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benson</surname><given-names>MJ</given-names></name><name><surname>Pino-Lagos</surname><given-names>K</given-names></name><name><surname>Rosemblatt</surname><given-names>M</given-names></name><name><surname>Noelle</surname><given-names>RJ</given-names></name></person-group>. <article-title>All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation</article-title>. <source>J Exp Med</source> (<year>2007</year>) <volume>204</volume>:<fpage>1765</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20070719</pub-id><?supplied-pmid 17620363?><pub-id pub-id-type="pmid">17620363</pub-id></mixed-citation></ref><ref id="B89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coombes</surname><given-names>JL</given-names></name><name><surname>Siddiqui</surname><given-names>KR</given-names></name><name><surname>Arancibia-Carcamo</surname><given-names>CV</given-names></name><name><surname>Hall</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>CM</given-names></name><name><surname>Belkaid</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism</article-title>. <source>J Exp Med</source> (<year>2007</year>) <volume>204</volume>:<fpage>1757</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20070590</pub-id><?supplied-pmid 17620361?><pub-id pub-id-type="pmid">17620361</pub-id></mixed-citation></ref><ref id="B90"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>CM</given-names></name><name><surname>Hall</surname><given-names>JA</given-names></name><name><surname>Blank</surname><given-names>RB</given-names></name><name><surname>Bouladoux</surname><given-names>N</given-names></name><name><surname>Oukka</surname><given-names>M</given-names></name><name><surname>Mora</surname><given-names>JR</given-names></name><etal/></person-group>
<article-title>Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid</article-title>. <source>J Exp Med</source> (<year>2007</year>) <volume>204</volume>:<fpage>1775</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20070602</pub-id><?supplied-pmid 17620362?><pub-id pub-id-type="pmid">17620362</pub-id></mixed-citation></ref><ref id="B91"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guilliams</surname><given-names>M</given-names></name><name><surname>Crozat</surname><given-names>K</given-names></name><name><surname>Henri</surname><given-names>S</given-names></name><name><surname>Tamoutounour</surname><given-names>S</given-names></name><name><surname>Grenot</surname><given-names>P</given-names></name><name><surname>Devilard</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Skin-draining lymph nodes contain dermis-derived CD103(-) dendritic cells that constitutively produce retinoic acid and induce Foxp3(+) regulatory T cells</article-title>. <source>Blood</source> (<year>2010</year>) <volume>115</volume>:<fpage>1958</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2009-09-245274</pub-id><?supplied-pmid 20068222?><pub-id pub-id-type="pmid">20068222</pub-id></mixed-citation></ref><ref id="B92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gatto</surname><given-names>D</given-names></name><name><surname>Wood</surname><given-names>K</given-names></name><name><surname>Caminschi</surname><given-names>I</given-names></name><name><surname>Murphy-Durland</surname><given-names>D</given-names></name><name><surname>Schofield</surname><given-names>P</given-names></name><name><surname>Christ</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>The chemotactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cells</article-title>. <source>Nat Immunol</source> (<year>2013</year>) <volume>14</volume>:<fpage>446</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2555</pub-id><?supplied-pmid 23502855?><pub-id pub-id-type="pmid">23502855</pub-id></mixed-citation></ref><ref id="B93"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>KL</given-names></name><name><surname>Caton</surname><given-names>ML</given-names></name><name><surname>Bogunovic</surname><given-names>M</given-names></name><name><surname>Greter</surname><given-names>M</given-names></name><name><surname>Grajkowska</surname><given-names>LT</given-names></name><name><surname>Ng</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Notch2 receptor signaling controls functional differentiation of dendritic cells in the spleen and intestine</article-title>. <source>Immunity</source> (<year>2011</year>) <volume>35</volume>:<fpage>780</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2011.08.013</pub-id><?supplied-pmid 22018469?><pub-id pub-id-type="pmid">22018469</pub-id></mixed-citation></ref><ref id="B94"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satpathy</surname><given-names>AT</given-names></name><name><surname>Briseno</surname><given-names>CG</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Ng</surname><given-names>D</given-names></name><name><surname>Manieri</surname><given-names>NA</given-names></name><name><surname>Kc</surname><given-names>W</given-names></name><etal/></person-group>
<article-title>Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens</article-title>. <source>Nat Immunol</source> (<year>2013</year>) <volume>14</volume>:<fpage>937</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2679</pub-id><?supplied-pmid 23913046?><pub-id pub-id-type="pmid">23913046</pub-id></mixed-citation></ref><ref id="B95"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tussiwand</surname><given-names>R</given-names></name><name><surname>Everts</surname><given-names>B</given-names></name><name><surname>Grajales-Reyes</surname><given-names>GE</given-names></name><name><surname>Kretzer</surname><given-names>NM</given-names></name><name><surname>Iwata</surname><given-names>A</given-names></name><name><surname>Bagaitkar</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Klf4 expression in conventional dendritic cells is required for T helper 2 cell responses</article-title>. <source>Immunity</source> (<year>2015</year>) <volume>42</volume>:<fpage>916</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2015.04.017</pub-id><?supplied-pmid 25992862?><pub-id pub-id-type="pmid">25992862</pub-id></mixed-citation></ref><ref id="B96"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Nish</surname><given-names>SA</given-names></name><name><surname>Jiang</surname><given-names>R</given-names></name><name><surname>Hou</surname><given-names>L</given-names></name><name><surname>Licona-Limon</surname><given-names>P</given-names></name><name><surname>Weinstein</surname><given-names>JS</given-names></name><etal/></person-group>
<article-title>Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>39</volume>:<fpage>722</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2013.08.028</pub-id><?supplied-pmid 24076050?><pub-id pub-id-type="pmid">24076050</pub-id></mixed-citation></ref><ref id="B97"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname><given-names>DB</given-names></name><name><surname>Sworder</surname><given-names>B</given-names></name><name><surname>Bouladoux</surname><given-names>N</given-names></name><name><surname>Roy</surname><given-names>CN</given-names></name><name><surname>Uchida</surname><given-names>AM</given-names></name><name><surname>Grigg</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Stromal-derived IL-6 alters the balance of myeloerythroid progenitors during <italic>Toxoplasma gondii</italic> infection</article-title>. <source>J Leukoc Biol</source> (<year>2012</year>) <volume>92</volume>:<fpage>123</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.1011527</pub-id><?supplied-pmid 22493080?><pub-id pub-id-type="pmid">22493080</pub-id></mixed-citation></ref><ref id="B98"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chorro</surname><given-names>L</given-names></name><name><surname>Sarde</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Woollard</surname><given-names>KJ</given-names></name><name><surname>Chambon</surname><given-names>P</given-names></name><name><surname>Malissen</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network</article-title>. <source>J Exp Med</source> (<year>2009</year>) <volume>206</volume>:<fpage>3089</fpage>&#x02013;<lpage>100</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20091586</pub-id><?supplied-pmid 19995948?><pub-id pub-id-type="pmid">19995948</pub-id></mixed-citation></ref><ref id="B99"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaitin</surname><given-names>DA</given-names></name><name><surname>Kenigsberg</surname><given-names>E</given-names></name><name><surname>Keren-Shaul</surname><given-names>H</given-names></name><name><surname>Elefant</surname><given-names>N</given-names></name><name><surname>Paul</surname><given-names>F</given-names></name><name><surname>Zaretsky</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types</article-title>. <source>Science</source> (<year>2014</year>) <volume>343</volume>:<fpage>776</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1126/science.1247651</pub-id><?supplied-pmid 24531970?><pub-id pub-id-type="pmid">24531970</pub-id></mixed-citation></ref><ref id="B100"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zigmond</surname><given-names>E</given-names></name><name><surname>Samia-Grinberg</surname><given-names>S</given-names></name><name><surname>Pasmanik-Chor</surname><given-names>M</given-names></name><name><surname>Brazowski</surname><given-names>E</given-names></name><name><surname>Shibolet</surname><given-names>O</given-names></name><name><surname>Halpern</surname><given-names>Z</given-names></name><etal/></person-group>
<article-title>Infiltrating monocyte-derived macrophages and resident Kupffer cells display different ontogeny and functions in acute liver injury</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>193</volume>(<issue>1</issue>):<fpage>344</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1400574</pub-id><?supplied-pmid 24890723?><pub-id pub-id-type="pmid">24890723</pub-id></mixed-citation></ref><ref id="B101"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ajami</surname><given-names>B</given-names></name><name><surname>Bennett</surname><given-names>JL</given-names></name><name><surname>Krieger</surname><given-names>C</given-names></name><name><surname>Tetzlaff</surname><given-names>W</given-names></name><name><surname>Rossi</surname><given-names>FM</given-names></name></person-group>. <article-title>Local self-renewal can sustain CNS microglia maintenance and function throughout adult life</article-title>. <source>Nat Neurosci</source> (<year>2007</year>) <volume>10</volume>:<fpage>1538</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1038/nn2014</pub-id><?supplied-pmid 18026097?><pub-id pub-id-type="pmid">18026097</pub-id></mixed-citation></ref><ref id="B102"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ajami</surname><given-names>B</given-names></name><name><surname>Bennett</surname><given-names>JL</given-names></name><name><surname>Krieger</surname><given-names>C</given-names></name><name><surname>Mcnagny</surname><given-names>KM</given-names></name><name><surname>Rossi</surname><given-names>FM</given-names></name></person-group>. <article-title>Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool</article-title>. <source>Nat Neurosci</source> (<year>2011</year>) <volume>14</volume>:<fpage>1142</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/nn.2887</pub-id><?supplied-pmid 21804537?><pub-id pub-id-type="pmid">21804537</pub-id></mixed-citation></ref><ref id="B103"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamasaki</surname><given-names>R</given-names></name><name><surname>Lu</surname><given-names>H</given-names></name><name><surname>Butovsky</surname><given-names>O</given-names></name><name><surname>Ohno</surname><given-names>N</given-names></name><name><surname>Rietsch</surname><given-names>AM</given-names></name><name><surname>Cialic</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Differential roles of microglia and monocytes in the inflamed central nervous system</article-title>. <source>J Exp Med</source> (<year>2014</year>) <volume>211</volume>:<fpage>1533</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20132477</pub-id><?supplied-pmid 25002752?><pub-id pub-id-type="pmid">25002752</pub-id></mixed-citation></ref><ref id="B104"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gautier</surname><given-names>EL</given-names></name><name><surname>Shay</surname><given-names>T</given-names></name><name><surname>Miller</surname><given-names>J</given-names></name><name><surname>Greter</surname><given-names>M</given-names></name><name><surname>Jakubzick</surname><given-names>C</given-names></name><name><surname>Ivanov</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages</article-title>. <source>Nat Immunol</source> (<year>2012</year>) <volume>13</volume>:<fpage>1118</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2419</pub-id><?supplied-pmid 23023392?><pub-id pub-id-type="pmid">23023392</pub-id></mixed-citation></ref><ref id="B105"><label>105</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavin</surname><given-names>Y</given-names></name><name><surname>Winter</surname><given-names>D</given-names></name><name><surname>Blecher-Gonen</surname><given-names>R</given-names></name><name><surname>David</surname><given-names>E</given-names></name><name><surname>Keren-Shaul</surname><given-names>H</given-names></name><name><surname>Merad</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment</article-title>. <source>Cell</source> (<year>2014</year>) <volume>159</volume>:<fpage>1312</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2014.11.018</pub-id><?supplied-pmid 25480296?><pub-id pub-id-type="pmid">25480296</pub-id></mixed-citation></ref><ref id="B106"><label>106</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>PJ</given-names></name><name><surname>Allen</surname><given-names>JE</given-names></name><name><surname>Biswas</surname><given-names>SK</given-names></name><name><surname>Fisher</surname><given-names>EA</given-names></name><name><surname>Gilroy</surname><given-names>DW</given-names></name><name><surname>Goerdt</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Macrophage activation and polarization: nomenclature and experimental guidelines</article-title>. <source>Immunity</source> (<year>2014</year>) <volume>41</volume>:<fpage>14</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2014.06.008</pub-id><?supplied-pmid 25035950?><pub-id pub-id-type="pmid">25035950</pub-id></mixed-citation></ref><ref id="B107"><label>107</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jha</surname><given-names>AK</given-names></name><name><surname>Huang</surname><given-names>SC</given-names></name><name><surname>Sergushichev</surname><given-names>A</given-names></name><name><surname>Lampropoulou</surname><given-names>V</given-names></name><name><surname>Ivanova</surname><given-names>Y</given-names></name><name><surname>Loginicheva</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization</article-title>. <source>Immunity</source> (<year>2015</year>) <volume>42</volume>:<fpage>419</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2015.02.005</pub-id><?supplied-pmid 25786174?><pub-id pub-id-type="pmid">25786174</pub-id></mixed-citation></ref><ref id="B108"><label>108</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siddiqui</surname><given-names>KR</given-names></name><name><surname>Laffont</surname><given-names>S</given-names></name><name><surname>Powrie</surname><given-names>F</given-names></name></person-group>. <article-title>E-cadherin marks a subset of inflammatory dendritic cells that promote T cell-mediated colitis</article-title>. <source>Immunity</source> (<year>2010</year>) <volume>32</volume>:<fpage>557</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2010.03.017</pub-id><?supplied-pmid 20399121?><pub-id pub-id-type="pmid">20399121</pub-id></mixed-citation></ref><ref id="B109"><label>109</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guilliams</surname><given-names>M</given-names></name><name><surname>Movahedi</surname><given-names>K</given-names></name><name><surname>Bosschaerts</surname><given-names>T</given-names></name><name><surname>Vandendriessche</surname><given-names>T</given-names></name><name><surname>Chuah</surname><given-names>MK</given-names></name><name><surname>Herin</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>IL-10 dampens TNF/inducible nitric oxide synthase-producing dendritic cell-mediated pathogenicity during parasitic infection</article-title>. <source>J Immunol</source> (<year>2009</year>) <volume>182</volume>:<fpage>1107</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.182.2.1107</pub-id><?supplied-pmid 19124754?><pub-id pub-id-type="pmid">19124754</pub-id></mixed-citation></ref><ref id="B110"><label>110</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuipers</surname><given-names>H</given-names></name><name><surname>Soullie</surname><given-names>T</given-names></name><name><surname>Hammad</surname><given-names>H</given-names></name><name><surname>Willart</surname><given-names>M</given-names></name><name><surname>Kool</surname><given-names>M</given-names></name><name><surname>Hijdra</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Sensitization by intratracheally injected dendritic cells is independent of antigen presentation by host antigen-presenting cells</article-title>. <source>J Leukoc Biol</source> (<year>2009</year>) <volume>85</volume>:<fpage>64</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.0807519</pub-id><?supplied-pmid 18923103?><pub-id pub-id-type="pmid">18923103</pub-id></mixed-citation></ref><ref id="B111"><label>111</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheong</surname><given-names>C</given-names></name><name><surname>Matos</surname><given-names>I</given-names></name><name><surname>Choi</surname><given-names>JH</given-names></name><name><surname>Dandamudi</surname><given-names>DB</given-names></name><name><surname>Shrestha</surname><given-names>E</given-names></name><name><surname>Longhi</surname><given-names>MP</given-names></name><etal/></person-group>
<article-title>Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas</article-title>. <source>Cell</source> (<year>2010</year>) <volume>143</volume>:<fpage>416</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2010.09.039</pub-id><?supplied-pmid 21029863?><pub-id pub-id-type="pmid">21029863</pub-id></mixed-citation></ref><ref id="B112"><label>112</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shalek</surname><given-names>AK</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name><name><surname>Adiconis</surname><given-names>X</given-names></name><name><surname>Gertner</surname><given-names>RS</given-names></name><name><surname>Gaublomme</surname><given-names>JT</given-names></name><name><surname>Raychowdhury</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Single-cell transcriptomics reveals bimodality in expression and splicing in immune cells</article-title>. <source>Nature</source> (<year>2013</year>) <volume>498</volume>:<fpage>236</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1038/nature12172</pub-id><?supplied-pmid 23685454?><pub-id pub-id-type="pmid">23685454</pub-id></mixed-citation></ref><ref id="B113"><label>113</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohl</surname><given-names>L</given-names></name><name><surname>Mohaupt</surname><given-names>M</given-names></name><name><surname>Czeloth</surname><given-names>N</given-names></name><name><surname>Hintzen</surname><given-names>G</given-names></name><name><surname>Kiafard</surname><given-names>Z</given-names></name><name><surname>Zwirner</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions</article-title>. <source>Immunity</source> (<year>2004</year>) <volume>21</volume>:<fpage>279</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2004.06.014</pub-id><?supplied-pmid 15308107?><pub-id pub-id-type="pmid">15308107</pub-id></mixed-citation></ref><ref id="B114"><label>114</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>MH</given-names></name><name><surname>Sougawa</surname><given-names>N</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Hirata</surname><given-names>T</given-names></name><name><surname>Hiroi</surname><given-names>T</given-names></name><name><surname>Tohya</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>176</volume>:<fpage>803</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.176.2.803</pub-id><?supplied-pmid 16393963?><pub-id pub-id-type="pmid">16393963</pub-id></mixed-citation></ref><ref id="B115"><label>115</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guilliams</surname><given-names>M</given-names></name><name><surname>Malissen</surname><given-names>B</given-names></name></person-group>. <article-title>A death notice for in-vitro-generated GM-CSF dendritic cells?</article-title>
<source>Immunity</source> (<year>2015</year>) <volume>42</volume>:<fpage>988</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2015.05.020</pub-id><?supplied-pmid 26084019?><pub-id pub-id-type="pmid">26084019</pub-id></mixed-citation></ref><ref id="B116"><label>116</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helft</surname><given-names>J</given-names></name><name><surname>Bottcher</surname><given-names>J</given-names></name><name><surname>Chakravarty</surname><given-names>P</given-names></name><name><surname>Zelenay</surname><given-names>S</given-names></name><name><surname>Huotari</surname><given-names>J</given-names></name><name><surname>Schraml</surname><given-names>BU</given-names></name><etal/></person-group>
<article-title>GM-CSF mouse bone marrow cultures comprise a heterogeneous population of CD11c(+)MHCII(+) macrophages and dendritic cells</article-title>. <source>Immunity</source> (<year>2015</year>) <volume>42</volume>:<fpage>1197</fpage>&#x02013;<lpage>211</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2015.05.018</pub-id><?supplied-pmid 26084029?><pub-id pub-id-type="pmid">26084029</pub-id></mixed-citation></ref><ref id="B117"><label>117</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wimmers</surname><given-names>F</given-names></name><name><surname>Schreibelt</surname><given-names>G</given-names></name><name><surname>Skold</surname><given-names>AE</given-names></name><name><surname>Figdor</surname><given-names>CG</given-names></name><name><surname>De Vries</surname><given-names>IJ</given-names></name></person-group>. <article-title>Paradigm shift in dendritic cell-based immunotherapy: from in vitro generated monocyte-derived DCs to naturally circulating DC subsets</article-title>. <source>Front Immunol</source> (<year>2014</year>) <volume>5</volume>:<fpage>165</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2014.00165</pub-id><?supplied-pmid 24782868?><pub-id pub-id-type="pmid">24782868</pub-id></mixed-citation></ref><ref id="B118"><label>118</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poulin</surname><given-names>LF</given-names></name><name><surname>Salio</surname><given-names>M</given-names></name><name><surname>Griessinger</surname><given-names>E</given-names></name><name><surname>Anjos-Afonso</surname><given-names>F</given-names></name><name><surname>Craciun</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>JL</given-names></name><etal/></person-group>
<article-title>Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells</article-title>. <source>J Exp Med</source> (<year>2010</year>) <volume>207</volume>:<fpage>1261</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20092618</pub-id><?supplied-pmid 20479117?><pub-id pub-id-type="pmid">20479117</pub-id></mixed-citation></ref><ref id="B119"><label>119</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bain</surname><given-names>CC</given-names></name><name><surname>Bravo-Blas</surname><given-names>A</given-names></name><name><surname>Scott</surname><given-names>CL</given-names></name><name><surname>Gomez Perdiguero</surname><given-names>E</given-names></name><name><surname>Geissmann</surname><given-names>F</given-names></name><name><surname>Henri</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice</article-title>. <source>Nat Immunol</source> (<year>2014</year>) <volume>15</volume>:<fpage>929</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2967</pub-id><?supplied-pmid 25151491?><pub-id pub-id-type="pmid">25151491</pub-id></mixed-citation></ref><ref id="B120"><label>120</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epelman</surname><given-names>S</given-names></name><name><surname>Lavine</surname><given-names>KJ</given-names></name><name><surname>Beaudin</surname><given-names>AE</given-names></name><name><surname>Sojka</surname><given-names>DK</given-names></name><name><surname>Carrero</surname><given-names>JA</given-names></name><name><surname>Calderon</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation</article-title>. <source>Immunity</source> (<year>2014</year>) <volume>40</volume>:<fpage>91</fpage>&#x02013;<lpage>104</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2013.11.019</pub-id><?supplied-pmid 24439267?><pub-id pub-id-type="pmid">24439267</pub-id></mixed-citation></ref><ref id="B121"><label>121</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molawi</surname><given-names>K</given-names></name><name><surname>Wolf</surname><given-names>Y</given-names></name><name><surname>Kandalla</surname><given-names>PK</given-names></name><name><surname>Favret</surname><given-names>J</given-names></name><name><surname>Hagemeyer</surname><given-names>N</given-names></name><name><surname>Frenzel</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Progressive replacement of embryo-derived cardiac macrophages with age</article-title>. <source>J Exp Med</source> (<year>2014</year>) <volume>211</volume>:<fpage>2151</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20140639</pub-id><?supplied-pmid 25245760?><pub-id pub-id-type="pmid">25245760</pub-id></mixed-citation></ref><ref id="B122"><label>122</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swirski</surname><given-names>FK</given-names></name><name><surname>Nahrendorf</surname><given-names>M</given-names></name><name><surname>Etzrodt</surname><given-names>M</given-names></name><name><surname>Wildgruber</surname><given-names>M</given-names></name><name><surname>Cortez-Retamozo</surname><given-names>V</given-names></name><name><surname>Panizzi</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Identification of splenic reservoir monocytes and their deployment to inflammatory sites</article-title>. <source>Science</source> (<year>2009</year>) <volume>325</volume>:<fpage>612</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1126/science.1175202</pub-id><?supplied-pmid 19644120?><pub-id pub-id-type="pmid">19644120</pub-id></mixed-citation></ref><ref id="B123"><label>123</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schraml</surname><given-names>BU</given-names></name><name><surname>Van Blijswijk</surname><given-names>J</given-names></name><name><surname>Zelenay</surname><given-names>S</given-names></name><name><surname>Whitney</surname><given-names>PG</given-names></name><name><surname>Filby</surname><given-names>A</given-names></name><name><surname>Acton</surname><given-names>SE</given-names></name><etal/></person-group>
<article-title>Genetic tracing via DNGR-1 expression history defines dendritic cells as a hematopoietic lineage</article-title>. <source>Cell</source> (<year>2013</year>) <volume>154</volume>:<fpage>843</fpage>&#x02013;<lpage>58</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2013.07.014</pub-id><?supplied-pmid 23953115?><pub-id pub-id-type="pmid">23953115</pub-id></mixed-citation></ref><ref id="B124"><label>124</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poltorak</surname><given-names>MP</given-names></name><name><surname>Schraml</surname><given-names>BU</given-names></name></person-group>. <article-title>Fate mapping of dendritic cells</article-title>. <source>Front Immunol</source> (<year>2015</year>) <volume>6</volume>:<fpage>199</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2015.00199</pub-id><?supplied-pmid 25999945?><pub-id pub-id-type="pmid">25999945</pub-id></mixed-citation></ref></ref-list></back></article>